TUBERCULOSIS 1 |
5 | ASSOCIATION BETWEEN NUTRITIONAL STATUS USING MALNUTRITION SCREENING TOOL AND BACTERIAL LOAD AMONG MDR-TB PATIENTS |
5 | PHARMACOVIGILANCE FOR PUBLIC HEALTH UTILITY: SAFETY MONITORING OF NEW REGIMEN FOR LATENT TUBERCULOSIS INFECTION TREATMENT |
5 | PUBLIC-PRIVATE MIX ACTIVITIES IN ENHANCING TUBERCULOSIS CASE NOTIFICATIONS IN SURABAYA, INDONESIA |
6 | GENEXPERT MTB/RIF FOR RAPID DIAGNOSIS AND RIFAMPIN RESISTANCE DETECTION OF ENDOBRONCHIAL TUBERCULOSIS |
6 | EFFICACY AND SAFETY OF DELAMANID FOR PULMONARY MULTI-DRUG RESISTANT TUBERCULOSIS |
6 | POLY-FUNCTIONAL CD8 T CELLS CAN DISCRIMINATE MAC LUNG DISEASE FROM AIRWAY COLONIZATION IN NON-HIV HOST |
6 | RARE EXTRAPULMONARY TUBERCULOSIS: FOUR CASES REPORT |
7 | QUANTIFERON-TB GOLD PLUS IS MORE SENSITIVE THAN QUANTIFERON-TB GOLD IN-TUBE FOR LATENT TUBERCULOSIS INFECTION AMONG RESIDENTS IN LONG-TERM CARE FACILITY |
BRONCHOSCOPY AND INTERVENTIONAL TECHNIQUES 1 |
7 | CHANGES IN VENTILATION AND PERFUSION FOLLOWING LOWER LOBE ENDOSCOPIC LUNG VOLUME REDUCTION (ELVR) WITH ENDOBRONCHIAL VALVES IN PATIENTS WITH SEVERE COPD |
8 | ANALYSIS OF 35 CASES OF BRONCHIAL FISTULA CURED BY IMPLANTATION OF NITINOL DOUBLE DRUM TYPE OCCLUDER |
8 | UTILITY AND SAFETY OF COBALT CHROMIUM NEEDLE FOR ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION (EBUS-TBNA) |
8 | USEFULNESS OF TRANSESOPHAGEAL BRONCHOSCOPIC ULTRASOUND-GUIDED FINE-NEEDLE ASPIRATION IN THE DIAGNOSIS OF MEDIASTINAL LESIONS ADJACENT TO THE OESOPHAGUS |
9 | IS BRONCHOSCOPY INDICATED IN PATIENTS WITH HAEMOPTYSIS WHEN THE CT IS NORMAL? |
9 | FEASIBILITY AND CLINICAL IMPACT OF RE-BIOPSY IN ADVANCED LUNG ADENOCARCINOMA AFTER PROGRESSES DURING FIRST-LINE EPIDERMAL GROWTH FACTOR RECEPTOR-TYROSINE KINASE INHIBITORS |
9 | THE ROLE OF CT-GUIDED PERCUTANEOUS TRANSTHORACIC NEEDLE BIOPSY WITH VIETNAM BIOPSY CALIBRATOR FOR THE DIAGNOSIS OF PULMONARY NODULES |
COPD 1 |
10 | LINKING AIRWAY GENE EXPRESSION AND LUNG MICROBIOME IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) |
10 | INVESTIGATING MICRORNA-MRNA INTERACTIONS IN THE COPD MICROENVIRONMENT BY NEXT-GENERATION SEQUENCING AND BIOINFORMATICS |
11 | THE EFFECT AND RELATED MECHANISM OF PHOSPHODIESTERASE 4 (PDE4) INHIBITOR ON CD4+ T LYMPHOCYTE PROLIFERATION |
11 | THE ROLE OF MIR-21/SMAD7/TGF-β PATHWAY IN COPD AND THE INFLUENCE ONACTIVATION OF TH17 CELL |
11 | DECREASED LEVELS OF PTEN, A NEGATIVE REGULATOR OF PHOSPHOINOSITIDE 3-KINASE (PI3K)/AKT PATHWAY, ARE CORRELATED WITH OBSTRUCTIVE IMPAIRMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
12 | OBSERVATION OF THE EFFECT OF METERED DOSE INHALERS AND ELECTRICAL IMPEDANCE TOMOGRAPHY PATTERNS ON MECHANICALLY VENTILATED PATIENTS WITH ACUTE EXACERBATION OF OBSTRUCTIVE PULMONARY DISEASES |
12 | SMALL MOLECULE C ENHANCES CELLULAR METABOLISM VIA CREB SIGNALLING IN EXPERIMENTAL MODELS OF COPD |
12 | CHANGES OF NEW EPIGENETIC MODIFICATIONS IN THE LUNGS OF CIGARETTE SMOKE EXTRACT-INDUCED MURINE EMPHYSEMA MODEL |
13 | PATTERN OF SPUTUM CULTURE IN ADULT PATIENTS WITH BRONCHIECTASIS IN THE TOP END OF AUSTRALIA |
CLINICAL RESPIRATORY MEDICINE 1 |
13 | ENDOTHELIN-1 INDUCES MESOTHELIAL MESENCHYMAL TRANSITION AND CORRELATES WITH PLEURAL FIBROSIS IN TUBERCULOUS PLEURAL EFFUSIONS |
13 | THE CORRELATION BETWEEN SMOKING STATUS AND URINARY COTININE LEVEL WITH FEF25–75% IN HIGH SCHOOL STUDENTS |
14 | IMPLEMENTATION OF COLLABORATIVE NURSING INTERVENTIONS AND POINTING AND CALLING FOR CHECKING AND DELIVERING VENTILATION PARAMETERS OF INVASIVE MECHANICAL VENTILATOR |
14 | ADDITIONAL ROLE OF BRONCHIAL MUCOSAL BIOPSY FOR CILIARY STRUCTURAL ABNORMALITY IN DIAGNOSIS OF PRIMARY CILIARY DYSKINESIA |
14 | EFFECT OF ORAL CHLORHEXIDINE IN PREVENTING HOSPITAL-ACQUIRED PNEUMONIA AMONG NON-INTUBATED PATIENTS IN THE PHILIPPINES |
15 | THE USE OF MEDICAL RESEARCH COUNCIL (MRC) DYSPNOEA GRADE IN PREDICTING PEAK OXYGEN UPTAKE AND WORK RATE IN UNDIFFERENTIATED DYSPNOEA. |
15 | PULMONARY REHABILITATION IN JAPAN: A POSITION STATEMENT FROM THE JSRCR/JSRPT/JRS |
RESPIRATORY STRUCTURE AND FUNCTION |
16 | CHRONIC INHALATION OF UNFLAVORED NICOTINE AND NO-NICOTINE CONTAINING ELECTRONIC CIGARETTE VAPOR LEADS TO IMPAIRED LUNG FUNCTION |
16 | ASTROCYTIC ACTIVATION IS NECESSARY FOR HYPOXIC RESPIRATORY FACILITATION |
16 | RETROSPECTIVE ANALYSIS OF FIVE YEARS ON SINGLE CENTER PULMONARY FUNCTION TEST |
17 | COMPARATIVE ANALYSIS OF PFT AND 3D LOW DOSE CHEST CT BASED LUNG VOLUME ASSESSMENTS IN SCOLIOSIS PATIENTS BEFORE AND AFTER SURGICAL CORRECTION |
17 | INTER-OPERATOR VARIABILITIES OF AIRWAY INDICES IN MDCT IMAGES OF COPD PATIENTS |
17 | SPIROMETER VALIDATION USING A FLOW/VOLUME SIMULATOR |
18 | QUANTITATIVE ASSESSMENT OF AIRWAY STRUCTURE USING ULTRA-HIGH RESOLUTION COMPUTED TOMOGRAPHY |
18 | THE VALUE OF RESPIRATORY BIPHASIC PULSE OSCILLATION INDEX IN DIFFERENTIAL DIAGNOSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ASTHMA AND THE DIAGNOSIS OF EMPHYSEMA |
LUNG CANCER 1 |
19 | FUNCTIONAL ANALYSIS OF MOB1 IN RESECTABLE LUNG ADENOCARCINOMA |
19 | FROM IMMUNOSURVEILLANCE TO IMMUNOEDITING: THE ROLE OF IMMUNOBIOLOGY IN EARLY LUNG CANCER DETECTION |
19 | GENETIC VARIANTS IN THE C-MYB SIGNALING PATHWAY GENES PREDICT SURVIVAL OF NON-SMALL CELL LUNG CANCER PATIENTS IN THE PLCO CANCER SCREENING TRIAL |
20 | NSCLC PATIENTS WITH BOTH WILDTYPE EGFR AND HIGH CD151 EXPRESSION HAVE POORER DISEASE OUTCOME |
20 | FACTORS PREDICTING THE EFFICACY OF OSIMERTINIB IN T790M-MUTATED METASTATIC LUNG ADENOCARCINOMA |
20 | THE CLINICAL ANALYSIS OF PULMONARY LYMPHOEPITHELIOMA-LIKE CARCINOMA WITH EPITHELIOID GRANULOMA: FOURTEEN CASES AND LITERATURE REVIEW |
21 | GEMCITABINE ENHANCES ANTI-TUMOR ACTIVITY OF PACLITAXEL BY MODULATING TUBULIN ACETYLATION |
21 | THE REAL-WORLD EFFICACY OF FIRST-LINE TYROSINE KINASE INHIBITORS IN ASIAN PATIENTS WITH EGFR MUTATION NON-SMALL CELL LUNG CANCER |
22 | MICRO RNA-21 TARGETING PI3K/PTEN/AKT SIGNALING AXIS REGULATES MULTIPLE BIOLOGICAL FUNCTIONS IN HUMAN LUNG CANCER |
CRITICAL CARE MEDICINE 1 |
22 | INTENSIVE CARE UNIT ADMISSION AND SURVIVAL IN STAGE IV CANCER PATIENTS WITH SEPTIC SHOCK: A POPULATION-BASED COHORT STUDY |
23 | NETS PROMOTES ALI/ARDS INFLAMMATION BY REGULATING ALVEOLAR MACROPHAGES POLARIZATION |
23 | A PREDICTIVE VALUE OF TRYPTOPHANYL-TRNA SYNTHETASE ON THE MORTALITY IN INTENSIVE CARE UNIT PATIENTS |
23 | ADD ON AZITHROMYCIN: REDUCE NOSOCOMIAL INFECTIONS AND VENTILATOR ASSOCIATED PNEUMONIA IN CRITICAL PEDIATRIC CARDIOVASCULAR SURGERY PATIENTS |
24 | PIRFENIDONE AMELIORATES LIPOPOLYSACCHARIDE-INDUCED PULMONARYINFLAMMATION AND FIBROSIS BY BLOCKING NLRP3 INFLAMMASOME ACTIVATION |
24 | INDUCED PLURIPOTENT STEM CELLS ATTENUATE ENDOTOXIN-INDUCED ACUTE LUNG INJURY VIA TREM-1 EXPRESSION TO REDUCE P38/IKB PATHWAY ACTIVITY |
24 | POINT-OF-CARE ULTRASOUND: A NEW CHOICE OF EARLY QUANTITATIVE DIAGNOSE OF PULMONARY EDEMA |
25 | EFFECTS OF ACID FIBROBLAST GROWTH FACTOR ON LIPOPOLYSACCHARIDES-INDUCED ACUTE LUNG INJURY IN RAT |
RESPIRATORY INFECTIONS (NON-TUBERCULOUS) 1 |
25 | EMPIRIC VANCOMYCIN TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA (CAP): INCREASING USE IN USA FROM 2007 TO 2015 AND POSSIBLE STRATEGY FOR DEESCALATION |
26 | PREDICTORS OF DEVELOPING MYCOBACTERIUM KANSASII PULMONARY INFECTION WITHIN 1 YEAR AMONG PATIENTS WITH SINGLE ISOLATION IN MULTIPLE SPUTUM SAMPLES |
26 | THE FIRST CASE OF COMMUNITY-ACQUIRED PRIMARY AND MULTIPLE LUNG ABSCESS DUE TO SEROTYPE K2 HYPERVIRULENT KLEBSIELLA PNEUMONIAE IN ADULT; AN EXTREMELY RARE CLINICAL COURSE |
27 | ANTIBIOTICS SUSCEPTIBILITY AND TREATMENT OUTCOMES OF MYCOBACTERIUM CHIMAERA PULMONARY DISEASE – A RETROSPECTIVE STUDY |
27 | NEXT GENERATION SEQUENCING ASSISTED PATHOGENIC DETECTION CAN IMPROVE OUTCOMES IN IMMUNOCOMPROMISED HOST WITH PULMONARY INFECTION |
28 | PROGNOSTIC VALUES OF CURB-65, EXPANDED-CURB-65, AND CURB-65 PLUS ALBUMIN AND PLATELET IN COMMUNITY ACQUIRED PNEUMONIA IN CIPTO MANGUNKUSUMO NATIONAL GENERAL HOSPITAL, JAKARTA |
ASTHMA 1 |
28 | DEVELOPMENT OF THE SEVERE ASTHMA TOOLKIT: A CLINICAL WEBSITE RESOURCE FOR THE MANAGEMENT OF SEVERE TREATMENT-REFRACTORY ASTHMA |
29 | ESTABLISHMENT OF EOSINOPHILIC BRONCHITIS MOUSE MODEL WITH NONINVASIVE LUNG FUNCTION TEST |
29 | IMPACT OF FRACTIONAL EXHALED NITRIC OXIDE MEASUREMENT ON MANAGEMENT OF PATIENTS WITH SUSPECTED ASTHMA |
29 | REDUCED NUCLEAR FACTOR-KB REPRESSING FACTOR AND INCREASED INTERLEUKIN-8 IN BRONCHIAL EPITHELIAL CELLS IN ASTHMA |
30 | THE EFFECTIVENESS OF MEPOLIZUMAB IN 19 PATIENTS WITH SEVERE ASTHMA IN JAPAN |
30 | METABONOMICS OF ALLERGIC ASTHMA: POTENTIAL BIOMARKERS HETES AND THEIR METABOLIC KEY ENZYME GPX |
31 | ANTI-REMODELLING FEATURES OF ARTESUNATE AS A POTENTIAL NOVEL DRUG FOR THE TREATMENT OF ASTHMA |
31 | THE PREVALENCE AND CLINICAL CHARACTERISTICS OF T2-LOW AND T2-HIGH ENDOTYPE OF SEVERE UNCONTROLLED ASTHMA DISTINGUISHED BY COMBINING TYPE-2 BIOMARKERS |
31 | MULTIDIMENSIONAL GAPS IN HEALTH CARE FACILITIES FOR ASTHMA PATIENTS IN INDONESIA; A FORMATIVE RESEARCH |
ENVIRONMENTAL & OCCUPATIONAL HEALTH AND EPIDEMIOLOGY |
32 | MESENCHYMAL STEM CELL-BASED THERAPY ATTENUATES SILICA-INDUCED MACROPHAGE ACTIVATION VIA CIRCZC3H4/ZC3H4 PATHWAY |
32 | LONG-TERM EXPOSURES TO AIR POLLUTANTS AND RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACES), A NATIONWIDE 10-YEAR OPEN COHORT STUDY IN TAIWAN |
33 | THE ROLE OF SIRTUIN1 IN THE MACROPHAGE POLARIZATION INDUCED DIRECTLY BY AIRBORNE PM2.5 |
33 | FINDING A HIDDEN ASBESTOS RELATED LUNG CANCER: MULTI-CENTERED ACTIVE SURVEILLANCE SYSTEM IN KOREA |
33 | HYPERCAPNIC ACIDOSIS ATTENUATES DECOMPRESSION SICKNESS-INDUCED LUNG INJURY |
34 | ASSOCIATION OF PHYSICAL ACTIVITY WITH LUNG FUNCTION IN DUSTY AREAS COHORT |
34 | LUTEOLIN DECREASES THE PM2.5-INDUCED AUTOPHAGY OF MH-S BY SCAVENGING ROS |
INTERSTITIAL LUNG DISEASE 1 |
35 | NINTEDANIB AND PIRFENIDONE INHIBIT LYSOPHOSPHATIDIC ACID-INDUCED VASCULAR ENDOTHELIAL GROWTH FACTOR AND COLLAGEN PRODUCTION IN HUMAN PRIMARY LUNG FIBROBLASTS |
35 | THE LONG TERM STUDY OF SIROLIMUS IN CHINESE POPULATION WITH LYMPHANGIOLEIOMYOMATOSIS |
35 | 10 YEARS-EXPERIENCE OF USING PIRFENIDONE FOR IDIOPATHIC PULMONARY FIBROSIS |
36 | PULMONARY ALVEOLAR PROTEINOSIS IN KOREA: ANALYSIS OF PREVALENCE AND INCIDENCE BY A NATIONWIDE POPULATION-BASED STUDY |
36 | THE PULMONARY MANIFESTATIONS OF TUBEROUS SCLEROSIS COMPLEX IN TAIWANESE PATIENTS |
37 | MORPHOLOGICAL ANALYSIS OF ALVEOLAR MACROPHAGE IN PATIENTS WITH SARCOIDOSIS: LET'S REFLECT THE CELL ON A BRONCHOALVEOLAR FLUID SPECIMEN-PART 2. |
37 | EXOSOMES-DERIVED FROM MACROPHAGES TREATED WITH ANGII PROMOTE LUNG FIBROSIS VIA ACTIVATING TGF-B/SMAD2/3 PATHWAY BY SHIFTING RAS TO ACE/ANGII/AT1R AXIS |
RESPIRATORY NEUROBIOLOGY AND SLEEP |
37 | CPAP PRESSURE IS ASSOCIATED WITH EFFECT OF MANDIBULAR ADVANCEMENT DEVICE FOR TREATING TREATMENT-NAÏVE PATIENTS WITH OSA |
38 | RELATIONSHIP BETWEEN OBSTRUCTIVE SLEEP APNOEA, OTHER CARDIOVASCULAR RISK FACTORS AND CARDIOVASCULAR DISEASE |
38 | NON-APNOEA SLEEP DISORDER INCREASES THE RISK OF INCIDENT HEART FAILURE-A NATIONWIDE POPULATION-BASED COHORT STUDY |
39 | DOES CHRONIC INTERMITTENT HYPOXIA ALWAYS INCREASE BLOOD GLUCOSE LEVELS IN MICE? |
39 | DECREASED MIR-21-5P AND MIR-23-3P EXPRESSIONS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA: A POTENTIAL PROTECTIVE EFFECT BY REGULATING TNF-ALPHA SIGNALING |
40 | PRENATAL CHRONIC INTERMITTENT HYPOXIA LEADS TO EARLY ATHEROSCLEROTIC LESIONS AND UPREGULATES CAVEOLIN-1 EXPRESSION IN RATS |
40 | UPPER AIRWAY IMAGING DURING A NOVEL INTRA-ORAL NEGATIVE PRESSURE DEVICE THERAPY IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA |
CLINICAL RESPIRATORY MEDICINE 2 |
41 | AUTOMATED ALERTING AND DECISION SUPPORT FOR REPORTING OF PHYSIOLOGIC DETERIORATION VIA A CLINICAL ALERTING SYSTEM IN PATIENTS WITH PNEUMONIA ADMITTED TO THE GENERAL WARDS |
41 | FIRST SUCCESSFUL CASE OF CHEMICAL PLEURODESIS WITH OXYTETRACYCLINE THROUGH ROCKET® PLEURAL VENT™ - AMBULATORY PNEUMOTHORAX DEVICE FOR PNEUMOTHORAX |
42 | SOUND-SPECTROGRAM WILL BE USEFUL IN THE DIFFERENTIAL DIAGNOSIS OF WHEEZES: BRONCHOSPASM OR FIXED AIRWAYS NARROWING? |
42 | CLINICAL CHARACTERISTICS OF CHRONIC COUGH: ADULT CHRONIC COUGH COHORT STUDY OF Republic of Korea |
43 | A COMPARATIVE STUDY ON THE DIAPHRAGM MUSCLE THICKNESS AND RAPID SHALLOW BREATHING INDEX (RSBI) AS A PREDICTOR FOR SUCCESSFUL EXTUBATION AMONG CRITICALLY ILL ADULT PATIENTS |
43 | QUALITY CHANGES OF CLINICAL PRACTICE GUIDELINES FOR RESPIRATORY DISEASES IN CHINA: A SYSTEMATIC APPRAISAL |
44 | CLINICAL PATHWAY AND DURATION OF HOSPITALIZATION IN PATIENTS WITH ACUTE EXACERBATION OF BRONCHIECTASIS |
BRONCHOSCOPY AND INTERVENTIONAL TECHNIQUES 2 |
44 | THE PROGNOSTIC PREDICTORS OF PATIENTS WITH AIRWAY INVOLVEMENT DUE TO ADVANCED OESOPHAGEAL CANCER AFTER METALLIC AIRWAY STENTING USING FLEXIBLE BRONCHOSCOPY |
44 | A MULTICENTRE, PROSPECTIVE TRIAL OF ELECTROMAGNETIC BRONCHOSCOPIC AND ELECTROMAGNETIC TRANSTHORACIC NAVIGATIONAL APPROACHES FOR THE BIOPSY OF PERIPHERAL PULMONARY NODULES (ALL IN ONE) |
45 | CRYOBIOPSY – A POTENTIAL TO BREAK THROUGH THE DIAGNOSTIC BRONCHOSCOPY FOR PERIPHERAL PULMONARY NODULES - |
45 | EVALUATION OF TRANSBRONCHIAL LUNG CRYOBIOPSY FREEZING TIME, CRYOBIOPSY SIZE, HISTOLOGICAL QUALITY AND INCIDENCE OF COMPLICATION: A PROSPECTIVE CLINICAL TRIAL |
45 | FEASIBILITY AND SAFETY OF CRYOBIOPSY IN INTERVENTIONAL BRONCHOSCOPY |
46 | EFFICACY AND SAFETY OF ARGON PLASMA COAGULATION (APC) PLUS PARTIALLY SPRAYED ADHESIVE VIA THORACOSCOPY IN THE TREATMENT OF SPONTANEOUS PNEUMOTHORAX PATIENTS WITH SUBPLEURAL BLEBS DISEASES |
COPD 2 |
46 | EARLY MANAGEMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
46 | THERAPEUTIC TARGETING OF THE IL-6 TRANS-SIGNALLING IN PULMONARY EMPHYSEMA |
47 | MMP-12 ACTIVATES PROTEASE ACTIVATED RECEPTOR (PAR)-1, UPREGULATES PLACENTA GROWTH FACTOR AND LEADS TO PULMONARY EMPHYSEMA |
47 | THE PROTECTIVE ROLE OF BRONCHIAL EPITHELIAL CELLS DERIVED EXOSOME IN COPD |
48 | ANDROGRAPHOLIDE SIMULTANEOUSLY AUGMENTS NRF2 ANTIOXIDANT DEFENSE AND FACILITATE AUTOPHAGIC FLUX BLOCKADE IN CIGARETTE SMOKE-EXPOSED HUMAN BRONCHIAL EPITHELIAL CELLS |
48 | PRMT6 MEDIATES INFLAMMATION VIA THE ACTIVATION OF NF-KB/P65 PATHWAY ON CIGARETTE SMOKE EXTRACT-INDUCED MURINE EMPHYSEMA MODEL |
48 | THE INFLAMMATORY CYTOKINE ENVIRONMENT OF COPD ALTERS THE AIRWAY EPITHELIAL RESPONSES TO VIRAL AND BACTERIAL STIMULI |
49 | CCL-1/CCL-2 INHIBITION BY ROLIPRAM IN MONOCYTES OF COPD |
49 | SODIUM TANSHINONE IIA SULFONATE INHIBITS CIGARETTE SMOKE-INDUCED INFLAMMATION AND OXIDATIVE STRESS IN MICE VIA INHIBITING AKT/HIF-1α SIGNALING PATHWAY |
PAEDIATRIC LUNG DISEASE |
49 | POST-OPERATIVE OUTCOME OF PAEDIATRIC EMPYEMA TREATED WITH VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS) |
50 | COMMUNITY-ACQUIRED NECROTIZING PNEUMONIA DUE TO METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS SECRETING PANTON-VALENTINE LEUKOCIDIN IN 4 PATIENTS ADMITTED TO CHILDREN'S HOSPITAL 1 IN NOVEMBER 2017: CASE SERIES REPORT |
50 | CHANGES AFTER AUTOMATED CONTROL OF INSPIRED OXYGEN CONCENTRATION IN PRETERM INFANT WHO UNDERWENT CPAP |
50 | SPONTANEOUS PNEUMOMEDIASTINUM WITH SUBCUTANEOUS EMPHYSEMA IN AN 8 YEAR OLD FEMALE: A CASE REPORT |
51 | DIAGNOSTIC VALUE OF SALIVARY LIQUEFIED CARBOHYDRATE ANTIGEN KL-6 IN CHILDREN WITH PNEUMONIA |
51 | PNEUMONIA DUE TO BURKHOLDERIA PSEUDOMALLEI IN CHILDREN AT THE CHILDREN'S HOSPITAL NO 1, HOCHIMINH-CITY, VIET NAM |
51 | PRIMARY CILIARY DYSKINESIA IN JAPAN |
52 | UTILITY OF FRACTIONAL EXHALED NITRIC OXIDE (FENO) LEVELS IN DIFFERENTIATINGUPPER RESPIRATORY TRACT INFECTION AND BRONCHIAL ASTHMA FROM HEALTHY NORMAL SCHOOL CHILDREN |
CRITICAL CARE MEDICINE 2 |
52 | PATHOGEN IDENTIFICATION WAS NOT ASSOCIATED WITH MORTALITY IN PATIENTS ADMITTED TO A MEDICAL INTENSIVE CARE UNIT WITH PNEUMONIA |
53 | PREDICTORS OF OUTCOME AMONG LUNG TRANSPLANTATION PATIENTS SUPPORTED WITH EXTRACORPOREAL MEMBRANE OXYGENATION |
53 | SEROTONIN AND VASCULAR PERMEABILITY (SEROTONIN BEYOND THE BRAIN) --- ANALYSIS OF SEROTONIN IN SEPSIS AND ARDS |
53 | PROTECTION EFFECT OF OVERWEIGHT AND OBESITY IN CRITICALLY ILL ADULT PATIENTS WITH INFLUENZA: A MULTICENTER RETROSPECTIVE COHORT STUDY IN TAIWAN |
54 | HIGH TIDAL VOLUME MECHANICAL VENTILATION REDUCES RESPIRATORY CENTER DRIVE BY POTASSIUM CHANNELS ALTERATION |
54 | UTILITY OF 6-MIN WALK TEST IN PREDICTING POST-OPERATIVE PULMONARY COMPLICATIONS AMONG PATIENTS UNDERGOING CARDIOTHORACIC SURGERIES |
55 | KINETICS OF OXYGEN UPTAKE DURING THE SPONTANEOUS BREATHING TRIAL PREDICTS WEANING OUTCOMES FOR PATIENTS WITH PROLONGED MECHANICAL VENTILATION: A PROSPECTIVE ANALYSIS AT A WEANING UNIT |
55 | NEUTROPHIL EXTRACELLULAR TRAPS AUGMENTED ALVEOLAR MACROPHAGES PYROPTOSIS IN LPS INDUCED ALI/ARDS |
PULMONARY CIRCULATION |
55 | CLINICAL COURSE AND OUTCOMES OF PATIENTS WITH SUBMASSIVE PULMONARY EMBOLISM |
56 | PREVALENCE OF VENOUS THROMBOEMBOLISM AMONG ADULT PATIENTS DIAGNOSED WITH CANCER AT ST. LUKE'S MEDICAL CENTER FROM 2010-2015 |
56 | FACTORS RELATED TO PULMONARY HYPERTENSION IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION |
57 | TRENDS IN HOSPITALIZATION AND MORTALITY OF VENOUS THROMBOEMBOLISM FROM 2007 TO 2016 IN CHINA |
ASTHMA 2 |
57 | ALTERED AIRWAY TRANSCRIPTOMICS AFTER BRONCHIAL THERMOPLASTY TREATMENT IN SEVERE ASTHMATICS |
57 | CORRELATION BETWEEN FUNGAL ALLERGEN EXTRACTS AND COMPONENTS OF ASPERGILLUS FUMIGATUS SIGE SENSITIZATION IN PATIENTS WITH RESPIRATORY TRACT ALLERGIC DISEASES IN SOUTHERN CHINA |
58 | SHORT TERM EFFICACY OF BENRALIZUMAB FOR SEVERE ASTHMATIC PATIENTS IN JAPAN |
58 | EFFECTIVENESS OF ASTHMA EDUCATION FOR NURSES USING AN ASTHMA CARE APPLICATION COMPARED TO A WRITTEN ASTHMA ACTION PLAN IN THAILAND |
58 | THE CLINICAL AND PATHOPHYSIOLOGICAL FEATURES OF COUGH-PREDOMINANT-ASTHMA |
59 | HIGH FRACTIONAL EXHALED NITRIC OXIDE LEVELS PREDICT SHORT-TERM WORSENING OF RESPIRATORY RESISTANCE |
59 | CAN FASTER ESCALATIONS IMPROVE THE EFFECTIVENESS OF ASTHMA ACTION PLANS? |
59 | THE CHARACTERISTICS OF SERUM HYDROXY-EICOSATETRAENOIC ACIDS IN ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS |
60 | VIETNAM HEALTHY LUNG PROGRAM – A SOLUTION TO FULFIL THE GAPS IN ASTHMA AND COPD MANAGEMENT |
TUBERCULOSIS 2 |
60 | LYMPHOCYTE LEVELS ASSOCIATION WITH BACTERIAL LOAD AND PULMONARY LESION FORM IN MDR TB PATIENT |
60 | THE ADHERENCE AND ADVERSE EFFECT OF USING PREVENTIVE THERAPY FOR LATENT TUBERCULOSIS THERAPY AMONG KIDNEY TRANSPLANT CANDIDATES |
61 | TREND OF MULTIDRUG-RESISTANT TUBERCULOSIS OVER 20 YEARS: DRUG RESISTANCE, TREATMENT OUTCOMES, AND ADVERSE EVENTS |
61 | INITIAL IMPLEMENTATION OF SHORTER REGIMEN FOR MDR-TB IN DR SOETOMO HOSPITAL, SURABAYA: THE PROPORTION BETWEEN ELIGIBILITY AND INELIGIBILITY |
61 | CHYLOUS EMPYEMA AND SECONDARY SPONTANEOUS PNEUMOTHORAX COMPLICATING PULMONARY TUBERCULOSIS |
62 | LUNG CANCER AND TUBERCULOSIS: COMPLEXITIES IN DIAGNOSIS AND MANAGEMENT |
62 | RESISTANCE PATTERN AMONG DRUG-RESISTANT TUBERCULOSIS PATIENTS IN INDONESIA |
63 | SEVEN DAYS OF FLUOROQUINOLONE EXPOSURE PRIOR TO TUBERCULOSIS DIAGNOSIS IS ASSOCIATED WITH AN INCREASED RISK OF MORTALITY |
CELL AND MOLECULAR BIOLOGY |
63 | IMMUNOLOCALIZATION OF ZINC TRANSPORTERS AND METALLOTHIONEINS SUPPORTS A POTENTIAL ROLE OF ZINC IN ENDOTHELIUM-SMOOTH MUSCLE CROSS TALK IN VASCULAR PHYSIOLOGY AND COPD |
63 | MITOFUSINS IN TYPE 2 ALVEOLAR CELLS ARE REQUIRED FOR METABOLIC ADAPTATION IN PULMONARY FIBROSIS |
64 | NEW INSIGHTS OF THE PATHOLOGY OF PULMONARY FIBROSIS REVEALED BY METABOLOME ANALYSIS ~ANTI-FIBROTIC FACTOR STANNIOCALCIN1 (STC1) AND SYSTEMIC DAMAGE RESPONSE~ |
64 | EXPERIMENTAL LUNG INJURY REDUCES KRÜPPEL-LIKE FACTOR 2 TO INCREASE ENDOTHELIAL PERMEABILITY VIA REGULATION OF RAPGEF3-RAC1 SIGNALING |
64 | TREATMENT WITH TRICHOSTATIN A RESTORES SENSITIVITY TO GEFITINIB AND IMPAIRS CANCER STEM CELLS FEATURES IN EGFR-MUTANT NON-SMALL CELL LUNG CANCER CELLS |
65 | REGULATIONAL MECHANISM OF CELL MOTILITY AND GM-CSF SECRETION BY P116RIP VIA MYOSIN AND CREB PHOSPHORYLATION IN HUMAN LUNG FIBROBLASTS |
65 | A NOVEL PEPTIDE WKYMVM HAS THERAPEUTIC EFFECT VIA IRF7/STAT1 PATHWAY AGAINST ENDOTOXIN-INDUCED ARDS |
65 | BIOLOGICAL EFFECTS OF PRETERM BIRTH ON AIRWAY DEVELOPMENT |
66 | THE EFFECT OF OBESITY ON THE EXPRESSION OF α7 NICOTINIC ACETYLCHOLINE RECEPTOR IN LPS-INDUCED LUNG INFLAMMATION |
RESPIRATORY INFECTIONS (NON-TUBERCULOUS) 2 |
66 | CLINICAL CHARACTERISTICS OF COMMUNITY-ACQUIRED PNEUMONIA DUE TO MORAXELLA CATARRHALIS IN ADULTS: A RETROSPECTIVE SINGLE CENTER STUDY |
66 | RELATIONSHIP BETWEEN INITIAL ANTIBIOTIC THERAPY AND OUTCOMES IN HOSPITALIZED PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA AT DR SOETOMO GENERAL HOSPITAL, SURABAYA |
67 | IN VITRO ANTIMICROBIAL SUSCEPTIBILITY AND TREATMENT OUTCOMES OF MOLECULAR DIAGNOSED MYCOBACTERIUM KANSASII PULMONARY DISEASE |
67 | OVERCOMING BIOFILM MEDIATED RESPIRATORY INFECTIONS THROUGH EXPLOITATION OF PATHOGEN AND HOST-DIRECTED NOVEL PEPTIDES |
68 | APPLICATION OF TRANSMISSION ELECTRON MICROSCOPY IN THE ETIOLOGIY DIAGNOSIS OF SEVERE PNEUMONIA VIA BALF: A RETROSPECTIVE STUDY |
68 | SERUM IGA ANTIBODIES AGAINST GLYCOPEPTIDOLIPID CORE ANTIGEN WITH SMOOTH OR ROUGH MORPHOTYPES IN PATIENTS WITH MYCOBACTERIUM ABSCESSUS COMPLEX LUNG DISEASE |
68 | THE CORRELATION ANALYSIS BETWEEN VIRUS LOADING AND SHEDDING WITH THE CLINICAL FEATURE OF PATIENTS INFECTED BY INFLUENZA VIRUS IN ADULT |
LUNG CANCER 2 |
69 | TAIWAN LUNG CANCER SCREENING PROGRAM FOR NEVER SMOKERS |
69 | CLINICAL IMPLICATION OF DNA METHYLATION ANALYSIS IN THE ORAL EPITHELIUM FOR LUNG CANCER RISK STRATIFICATION |
70 | METABOLIC PROFILING CLASSIFIES NON-SMALL CELL LUNG CANCER CELLS INTO DIFFERENT SUBTYPES WITH DISTINCT SENSITIVITIES TO METABOLIC INHIBITIONS |
70 | ANGIOTENSIN-(1-7) SUPPRESSES NSCLC ACQUIRED PLATINUM RESISTANCE-INDUCED TUMOR ANGIOGENESIS VIA PI3K/AKT AND MAPK SIGNALING PATHWAYS |
70 | THE ROLE OF THE GROUND-GLASS OPACITY RATIO IN RESECTED LUNG ADENOCARCINOMA |
71 | DIFFERENTIAL C-TERMINAL PROTEIN FRAGMENTS OF α-1-MICROGLOBULIN/BIKUNIN PRECURSOR AS POTENTIAL MAKER FOR EARLY DETECTION OF LUNG ADENOCARCINOMA |
71 | PHOSPHORYLATION OF THE CYTOSKELETAL PROTEIN CAP1 REGULATES NON-SMALL CELL LUNG CANCER SURVIVAL AND PROLIFERATION BY GSK3β |
71 | EPIGENETIC THERAPY MODULATES POLYFUNCTIONALITY OF TUMOR-REACTIVE T CELLS IN NON-SMALL CELL LUNG CANCER |
72 | PROGRESSION-FREE SURVIVAL AMONG PROGRESSED NON-SMALL CELL LUNG CANCER (NSCLC) WITH T790M MUTATION AS GUIDED BY LIQUID BIOPSY IS SHORTER THAN THOSE BASED ON TISSUE RE-BIOPSY |
TUBERCULOSIS 3 |
72 | ADVERSE REACTIONS AMONG PATIENTS BEING TREATED WITH SHORTER MULTI-DRUG RESISTANT TUBERCULOSIS REGIMEN AT PERSAHABATAN HOSPITAL, INDONESIA |
73 | THE MYELOID DERIVED SUPPRESSOR CELLS INCREASED PREDOMINANTLY IN LATENT TUBERCULOSIS INFECTION WHILE REGULATORY T CELLS ELEVATED IN TB REACTIVATION |
73 | HOW EFFECTIVE IS THE SYSTEMIC INTEGRATION OF SMOKING CESSATION INTO TUBERCULOSIS CONTROL PROGRAMME IN CREATING SMOKE-FREE ENVIRONMENTS IN THE PHILIPPINES? |
74 | CORRELATION BETWEEN CLINICAL MANIFESTATION AND SEVERITY OF TUBERCULOSIS DISEASE (A MULTI-CENTRE STUDY IN INDONESIA) |
74 | ENDOBRONCHIAL LESION IN PATIENTS WITH SMEAR-NEGATIVE PULMONARY TUBERCULOSIS |
74 | PROLONGED QT AND TORSADE DE POINTES IN PATIENT WITH XDR TUBERCULOSIS TREATED WITH BEDAQUILLINE |
75 | CD8 RESPONSE MEASURED BY QUANTIFERON-TB GOLD PLUS AND TUBERCULOSIS DISEASE STATUS |
75 | A RARE ENTITY: DISSEMINATED TUBERCULOSIS WITH EVANS SYNDROME |
CLINICAL ALLERGY AND IMMUNOLOGY |
75 | AN EVIDENCE-BASED MEDICINE FOLLOW-UP AND COMPARISON STUDY ON ATOPIC UPPER AND LOWER AIRWAY DISORDER |
75 | INCREASED NUMBERS OF GROUP 2 INNATE LYMPHOID CELLS IN THE AIRWAYS OF PATIENTS WITH EOSINOPHILIC BRONCHITIS |
76 | ASIA-PACIFIC SURVEY OF PHYSICIANS ON ASTHMA AND ALLERGIC RHINITIS (ASPAIR): DATA FOR GENERAL PRACTITIONERS COMPARED TO PAEDIATRICIANS |
76 | INCREASED NUMBERS OF CD4+CRTH2+ T CELLS IN THE AIRWAYS OF PATIENTS WITH EOSINOPHILIC BRONCHITIS |
INTERSTITIAL LUNG DISEASE 2 |
77 | IMPAIRMENT OF LUNG DIFFUSE FUNCTION IN PATIENTS WITH PULMONARY LYMPHANGIOMYOMATOSIS (LAM) |
77 | LONG-TERM TREATMENT WITH NINTEDANIB IN ASIAN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS: RESULTS FROM INPULSIS-ON |
78 | NON-INTERVENTIONAL STUDY COLLECTING EXPERIENCES FOR IPF IN TAIWAN (NICEFIT STUDY): INTERIM REPORT |
78 | EFFECT OF TOCILIZUMAB ON INTERSTITIAL LUNG DISEASE IN PATIENTS WITH RHEUMATOID ARTHRITIS |
78 | DOES FEF25–75 DISTINGUISH BETWEEN AIRWAY OBSTRUCTION AND RESTRICTION IN DPLD? |
79 | CIGARETTE SMOKING CAN AGGRAVATE PULMONARY FIBROSIS BY INDUCING ALVEOLAR EPITHELIAL CELL II SENESCENCE |
COPD 3 |
79 | HEART RATE VARIABILITIES BIOFEEDBACK AS AN ADJUNCT TO PULMONARY REHABILITATIVE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
80 | FACTORS ASSOCIATED WITH NON-ATTENDANCE TO PULMONARY REHABILITATION IN CANTERBURY, NEW ZEALAND |
80 | IMPACT OF MUSIC THERAPY ON CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS |
81 | EFFICACY AND SAFETY OF GLYCOPYRRONIUM/FORMOTEROL FUMARATE DIHYDRATE METERED DOSE INHALER (GFF MDI) DELIVERED USING CO-SUSPENSION DELIVERY TECHNOLOGY IN CHINESE PATIENTS WITH COPD |
81 | BENEFITS AND RISKS OF INHALED CORTICOSTEROID TREATMENT IN PATIENTS WITH COPD CLASSIFIED BY BLOOD EOSINOPHIL COUNTS |
82 | CLINICAL COURSE OF COPD PATIENTS WITH BOTH EMPHYSEMA AND AIRWAY WALL THICKENING ON CT COMPARED TO OTHER PHENOTYPES |
82 | FOUR-WEEKS REMOTE PULMONARY REHABILITATION PROTOCOL WITH MOBILE APPS OF REAL-TIME HEART RATE MONITORING FOR GOLD CATEGORY B/C/D- A STUDY DESIGN |
LUNG CANCER 3 |
83 | IMMUNOLOGICAL ANALYSIS OF PLEURAL EFFUSION IN CANCER PATIENTS WHO RECEIVED IMMUNE CHECKPOINT INHIBITORS (ICI) FOR THE DEVELOPMENT OF BIOMARKERS |
83 | STUDY OF SYNERGISTIC EFFECT OF METFORMIN WITH PEMETREXED IN LUNG CANCER THERAPY VIA ORTHOTOPIC LUNG INJECTION FLUORESCENT MICE TUMOR MODEL |
83 | ADENYLATE CYCLASE-ASSOCIATED PROTEIN 1-TARGETED NANOPARTICLES AS A NOVEL STRATEGY FOR THE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER |
84 | INCIDENCE OF BRAIN METASTASIS IN PATIENT WITH NEWLY DIAGNOSED LUNG ADENOCARCINOMA |
84 | ASSOCIATION BETWEEN LIQUID BIOPSY AND TISSUE BIOPSY FOR EGFR MUTATION IN LUNG ADENOCARCINOMA |
85 | MIR-126* AND MIR-145 AS POTENTIAL BIOMARKERS FOR NON-SMALL CELL LUNG CANCER |
85 | MIR-204 RESTORES THE EGFR TYROSINE KINASE INHIBITOR-SENSITIVITY THROUGH ATTENUATING EPITHELIAL TO MESENCHYMAL TRANSITION AND CANCER STEMNESS |
85 | EVALUATION OF THE EFFICACY AND SAFETY OF INTRAPLEURAL INJECTION OF BEVACIZUMAB TREATMENT OF MALIGNANT PLEURAL EFFUSION CAUSED BY LUNG ADENOCARCINOMA |
AWARD SESSION |
86 | CLINICAL SIGNIFICANCE OF ASPERGILLUS SPECIES ISOLATED FROM RESPIRATORY SPECIMENS IN PATIENTS WITH MYCOBACTERIUM AVIUM COMPLEX LUNG DISEASE |
86 | COMBINATION THERAPY WITH NINTEDANIB AND PREDNISOLONE IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS |
87 | A QUALITATIVE STUDY EXPLORING THE BARRIERS AND CHALLENGES TO ASTHMA MANAGEMENT AS PERCEIVED BY MALAYSIAN ASTHMATIC PATIENTS |
87 | EVALUATION OF UPPER AIRWAY (UA) ANTHROPOMETRY USING MAGNETIC RESONANCE IMAGING (MRI) AND LATERAL CEPHALOMETRY IN PATIENTS OF OBSTRUCTIVE SLEEP APNEA (OSA) IN NORTH INDIAN POPULATION. |
87 | IDENTIFICATION OF A NEW TARGET FOR DIAGNOSING IDIOPATHIC PULMONARY FIBROSIS WITH AUTOIMMUNE FEATURES |
88 | ENDOSOMAL NOX2 OXIDASE INHIBITOR PROTECTS AGAINST HIGHLY PATHOGENIC INFLUENZA VIRUS MORBIDITY |
88 | EPIGENETIC REGULATION OF FZD9 AND ILOPROST LUNG CANCER CHEMOPREVENTION |
88 | A MULTI-LEVEL APPROACH TO ASTHMA HEALTH DISPARITIES: FROM BIOMARKERS TO GEOCODED DATA |
PULMONARY CIRCULATION |
89 | PULMONARY HYPERTENSION IN CPFE (COMBINED PULMONARY FIBROSIS AND EMPHYSEMA) |
ASTHMA 1 |
90 | CHANGES IN FRACTIONAL NITRIC OXIDE CONCENTRATION IN EXHALED BREATH WITH THE USE OF ICS/LABA INHALERS |
90 | FEF25–75 IS THE BETTER DIAGNOSTIC TOOL FOR IDENTIFYING ASTHMA PATIENTS |
90 | HEALTHY LUNG ASIA INITIATIVE |
91 | ANCA NEGATIVE EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: 4 CASES REPORT AND LITERATURE REVIEW |
91 | COMMON MICRORNA CHANGES IN BRONCHIAL EPITHELIAL CELLS OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASES |
91 | S1P/S1PR3 PATHWAY HAS THE ROLE IN EOSINOPHILIC AIRWAY INFLAMMATION VIA RELEASE OF CCL20 FROM BRONCHIAL EPITHELIAL CELLS |
91 | ALLERGIC SENSITIZATION PROFILE OF POLYSENSITIZED ASTHMATIC PATIENTS IN SOUTHERN CHINA USING MOLECULE-BASED IGE TECHNIQUE |
92 | PREDICTORS TO THE EXACERBATION OF BRONCHIAL ASTHMA AMONG CHILDREN BETWEEN 6–18 YEARS OLD AT CHONG HUA HOSPITAL |
92 | POST HOC ANALYSIS OF INITIAL TREATMENTS AND CONTROL STATUS USING DIFFERENT GINA CRITERIA IN INITIAL, AN OBSERVATIONAL STUDY OF NEWLY DIAGNOSED CHINESE PATIENTS WITH ASTHMA |
93 | SMALL AIRWAY DYSFUNCTION PREDICTED FIXED AIRFLOW OBSTRUCTION IN OLDER ASTHMA PATIENTS |
93 | CHITIN INDUCED PRODUCTION OF PROSTAGLANDIN E2 IN ALVEOLAR MACROPHAGES AND BRONCHIAL EPITHELIAL CELLS |
93 | THE LEVEL OF PLASMINOGEN ACTIVATOR INHIBITORS 1 IN ASTHMA PATIENTS AND CORRELATION WITH LUNG FUNCTION AND DEGREE OF ASTHMA CONTROL |
94 | CORELATION BETWEEN INHALED BETA-2 AGONIST AND CORTICOSTEROID WITH THE DEGREE OF ASTHMA CONTROL AND LUNG FUCTION |
94 | THE ROLE OF APS F 6 THE COMPONENT OF ASPERGILLUS FUMIGATUS ON THE IDENTIFYING ABPA AND ASTHMA |
94 | ASSOCIATION OF PSORIASIS WITH ASTHMA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES |
95 | PERCEPTION OF DOCTORS ABOUT DIAGNOSIS, MANAGEMENT AND FACING THE CHALLENGES WITH THEIR PATIENTS WITH ASTHMA: AN OBSERVATION-BASED SURVEY IN NEPAL |
95 | ROUTINE BENZODIAZEPINE USE MAY NOT INCREASE THE FREQUENCY OF ASTHMA EXACERBATIONS |
96 | THE EFFECT OF USING MOBILE APP FOR TRAINING NURSES ON CORRECT USE OF INHALER DEVICES |
96 | A SURVEY ON THE MORBIDITY AND COST OF MULTIPLE CHRONIC CONDITIONS IN ASTHMA PATIENTS |
96 | DIFFERENT IMPACTS OF COMORBIDITY OF ALLERGIC RHINITIS ON OBESE AND NON-OBESE PATIENTS WITH ASTHMA |
97 | INHIBITION OF MAB ON PROLIFERATION AND MIGRATION OF ASMCS INDUCED BY PDGF-BB AND ITS EFFECTS ON MITOCHONDRIA |
97 | RETROSPECTIVE STUDY TOTAL SERUM IMMUNOGLOBULIN E, ALLERGEN-SPECIFIC IGE PROFILE AND PERIPHERAL BLOOD EOSINOPHILIA PERCENTAGE IN MODERATE TO SEVERE ASTHMATIC PATIENTS IN RESPIRATORY CLINIC, TAIPING HOSPITAL |
97 | RESPONSE OF GOBLET CELLS OF BRONCHIAL EPITHELIUM IN PATIENTS WITH MILD ASTHMA AND COLD AIRWAY HYPERRESPONSIVENESS TO REGULAR CONTROLLER THERAPY WITH INHALED CORTICOSTEROIDS |
98 | HEALTHY LUNG PROGRAMME: AN INITIATIVE FROM TSPCCM (TAIWAN SOCIETY OF PULMONARY AND CRITICAL CARE MEDICINE) AND ASTRAZENECA (AZ) TAIWAN TO IMPROVE TAIWAN ASTHMA MANAGEMENT |
98 | THE RATIO OF NEURAL DRIVE TO TIDAL VOLUME MEASURED FROM SURFACE ELECTRODES CAN DETECT CLINICALLY SIGNIFICANT FALLS IN FEV1 IN ASTHMATIC SUBJECTS DURING HISTAMINE CHALLENGE |
98 | RISK FACTORS AND MECHANISM FOR ANXIETY AND DEPRESSION IN CHINESE ADULTS WITH ASTHMA |
BRONCHOSCOPY AND INTERVENTIONAL TECHNIQUES 1 |
99 | USING GUIDING DEVICE AS ASSISTED TOOL WITH ENDOBRONCHIAL ULTRASOUND TRANSBRONCHIAL BIOPSY TO GET ADEQUATE REBIOPSY SAMPLE |
99 | RADIAL PROBE ENDOBRONCHIAL ULTRASOUND ASSISTED CONVENTIONAL TRANSBRONCHIAL NEEDLE ASPIRATION IN THE DIAGNOSIS OF SOLITARY PERIBRONCHIAL PULMONARY LESION LOCATED IN THE SEGMENTAL BRONCHI |
100 | A NOVEL METHOD FOR TREATING THE REFRACTORY AND SEVERE BENIGN CENTRAL AIRWAY STENOSIS WITH OSCILLATING POSITIVE EXPIRATORY PRESSURE: TWO CASES REPORT |
100 | A CASE OF BRONCHIAL FOREIGN BODY ASPIRATION CAUSED BY JAPANESE SPINY LOBSTER'S ANTENNA |
100 | A CASE OF BRONCHIAL MUCOEPIDERMOID CARCINOMA TREATED BY PHOTODYNAMIC THERAPY |
101 | DOES BRONCHOSCOPY HAVE A RISK OF POSTOPERATIVE RECURRENCE? |
101 | FACTORS INFLUENCE THE DIAGNOSTIC YIELD OF ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL BIOPSY IN PERIPHERAL PULMONARY LESIONS |
102 | SAFETY EVALUATION OF RIGID BRONCHOSCOPIES AND THE RAPEUTIC PROCEDURES |
102 | USE OF CRYOBIOPSY DURING SEMI-RIGID PLEUROSCOPY |
103 | ENDOBRONCHIAL BALLOON TAMPONADE ACHIEVING SUCCESSFUL CONTROL OF MASSIVE HAEMOPTYSIS SECONDARY TO METASTATIC LUNG DISEASE: A CASE REPORT |
103 | EVALUATION THE PHYSIOLOGICAL CHANGES OF CENTRAL AIRWAY ON MULTI-DETECTOR COMPUTED TOMOGRAPHY |
103 | INITIAL EXPERIENCE ON PERCUTANEOUS CATHETER DRAINAGE FOR RESPIRATORY DISEASES IN SRI LANKA: AN AUDIT |
104 | A CASE OF RIGHT LUNG REEXPANSION DUE TO TRACHEAL PERFORATION |
104 | THE IMPACT OF THE HIGH-FLOW NASAL OXYGEN TO THE SAFETY AND SEDATIVE QUALITY OF PATIENTS UNDERGOING BRONCHOSCOPY- PRELIMINARY DATA |
105 | A SIMPLIFIED METHOD OF TRANSESOPHAGEAL NEEDLE ASPIRATION WITH AN ULTRASOUND-GUIDED BRONCHOSCOPE (EBUS-TENA) |
105 | MOLECULAR ANALYSIS OF SMALL TISSUE SAMPLES OBTAINED VIA TRANSBRONCHIAL LUNG BIOPSY USING RADIAL PROBE ENDOBRONCHIAL ULTRASOUND |
105 | IS UNIPORTAL VIDEO-ASSISTED THORACOSCOPIC SURGERY ACCEPTABLE AS A STANDARD SURGICAL TECHNIQUE FOR THE PRIMARY SPONTANEOUS PNEUMOTHORAX? |
106 | CASE STUTY DOUBLE STENTING OF OESOPHAGUS AND AIRWAY IN PALLIATIVE TREATMENT OF PATIENT WITH OESOPHAGEAL CANCER |
106 | FLEXIBLE BRONCHOSCOPE INTERVENTIONAL THERAPY UNDER MECHANICAL VENTILATION FOR SEVERE AIRWAY STENOSIS: CASE REPORTS |
106 | RECURRENT PNEUMOTHORAX IN SJOGREN SYNDROME |
107 | SUGAR FROSTING-LIKE LESION IS A HINT OF MESOTHELIAL HYPERPLASIA UNDER PLEUROSCOPY: A CASE REPORT |
107 | BRONCHIAL OCCLUSION WITH ENDOBRONCHIAL WATANABE SPIGOT FOR HAEMOPTYSIS IN A MECHANICALLY VENTILATED PATIENT WITH EXTRACORPOREAL CIRCULATION |
107 | FEASIBILITY AND SAFETY OF FLEXIBLE BRONCHOSCOPY-GUIDED MICROWAVE ABLATION IN PORCINE LUNG: A NEW IMAGE-GUIDED MICRO-INVASIVE ABLATION METHOD FOR LUNG LESIONS |
108 | IMPROVED HOSPITALISATION STAY WITH INDWELLING PLEURAL CATHETER |
108 | MANAGEMENT OF EARLY AIRWAY RESTENOSIS AFTER THE PLACEMENT OF METAL COVERED STENT: A CASE REPORT |
CELL AND MOLECULAR BIOLOGY 1 |
109 | THE ASSOCIATION OF VANADIUM PENTOXIDE AND INFLAMMATORY RESPONSE IN PATIENTS WITH COPD AND IN HUMAN BRONCHIAL EPITHELIAL CELL |
109 | GENETIC ASSOCIATION OF RS2227589 POLYMORPHISM WITH PULMONARY EMBOLISM RISK IN CHINESE POPULATION |
109 | MITOCHONDRIAL MEMBRANE POTENTIAL IN CHILDRENWITH INTERSTITIAL LUNG DISEASES (ILD) |
110 | INHIBITION OF NEUTROPHIL ELASTASE CONTRIBUTES TO ATTENUATION OF LIPOPOLYSACCHARIDE INDUCED ACUTE LUNG INJURY DURING NEUTROPENIA RECOVERY IN MICE |
110 | DUAL BRONCHODILATOR SUPPRESSES CIGARETTE SMOKE EXTRACT-INDUCED AUTOPHAGIC CELL DEATH IN HUMAN BRONCHIAL EPITHELIAL CELLS |
110 | SPECIFIC SPHINGOSINE KINASE 1 INHIBITOR, SK1-I ATTENUATES NEUTROPHIL ELASTASE INDUCED AIRWAY INFLAMMATION AND GOBLET CELL HYPERPLASIA IN MICE |
111 | TILIROSIDE CAN MODULATE UPPER AIRWAY SECRETION BY THE INHIBITION OF CALCIUM ACTIVATED CL- CHANNEL, ANO1 |
111 | REGULATORY MECHANISMS OF SYSTEMIC INFLAMMATION IN RESPIRATORY PATHOLOGY |
111 | POLARIZATION OF ALVEOLAR MACROPHAGE IN MODEL OF DIET INDUCED OBESE MICE WITH VENTILATOR INDUCED LUNG INJURY |
112 | DEVELOPMENT OF A METHOD TO PREDICT THE PERSISTENT PULMONARY INFLAMMATION BY NANOPARTICLES AT AN EARLY STAGE WITH GENE EXPRESSION LEVEL |
112 | DICHLOROACETATE, AN INHIBITOR OF AEROBIC GLYCOLYSIS, AMELIORATES NEUTROPHILIC AIRWAY INFLAMMATION THROUGH SUPPRESSING TH17 POPULATION AND INDUCING REGULATORY T CELL POPULATION |
CLINICAL ALLERGY AND IMMUNOLOGY 1 |
112 | PREVALENCE AND CLINICAL CHARACTERISTICS OF AIRWAY DISEASES IN PATIENTS WITH ULCERATIVE COLITIS |
113 | ANALYSIS OF ADVERSE REACTIONS AND RISK FACTORS TO SCIT IN CHILDREN WITH ALLERGIC |
113 | ASIA-PACIFIC SURVEY OF PHYSICIANS ON ASTHMA AND ALLERGIC RHINITIS (ASPAIR): DATA FOR THREE HYPOTHETICAL CASE STUDIES |
114 | UNCONTROLLED BRONCHIAL ASTHMA: A RARE CASE OF CHURG-STRAUSS SYNDROME |
114 | ANALYSIS OF DISTRIBUTION CHARACTERISTICS OF TIGE AND SIGE IN PATIENTS WITH RESPIRATORY ALLERGIC DISEASES |
114 | MAPPING MIMOTOPES FOR HOUSE DUST MITE ALLERGEN DER F 7 USING A SPECIFIC MONOCLONAL ANTIBODY |
CLINICAL RESPIRATORY MEDICINE 1 |
115 | THYMOMA (WORLD HEALTH ORGANIZATION TYPE B3) WITH NEUROENDOCRINE DIFFERENTIATION: A RARE TYPE OF THYMOMA |
115 | PNEUMOCONIOSIS FOLLOWING CHRONIC CHARCOAL DUST EXPOSURE: DESCRIPTION OF A RARE ASSOCIATION AND A CASE PRESENTATION |
115 | QUANTIFYING MYELOID-DERIVED SUPPRESSOR CELLS IN PLEURAL EFFUSION CAN DISTINGUISH TUBERCULOSIS FROM PNEUMONIA |
116 | SAFETY OF PRE-OPERATIVE PULMONARY FUNCTION TESTING IN LEFT MAIN CORONARY ARTERY DISEASE |
116 | APPLICATION OF NOCTURNAL OXYGEN THERAPY/BILEVEL POSITIVE AIRWAY PRESSURE (BIPAP) TO TREAT PATIENTS WITH CHRONIC LUNG DISEASE AND NOCTURNAL OXYGEN DESATURATION WHO REQUIRED HOSPITALIZATION |
116 | A CASE OF EMPYEMA CAUSED BY ESOPHAGOPLEURAL FISTULA SUCCESSFULLY TREATED WITH SELF-EXPANDABLE METALLIC STENT |
117 | INFECTED BULLOUS LUNG DISEASE |
117 | SKIN DEEP: A CASE OF DERMATOMYOSITIS INITIALLY PRESENTING WITH PLEURAL EFFUSION |
117 | LONG UVULA: AN UNUSUAL CAUSE OF CHRONIC COUGH IN AN ADULT |
118 | PLEURA-CONTACT SIGN FOR PREDICTING INDETERMINATE LUNG NODULES IN PATIENTS WITHOUT CANCER HISTORY |
118 | A RARE CASE OF ADOLESCENT IDIOPATHIC SCOLIOSIS WITH RIGHT LUNG AGENESIS IN A 16 YEAR OLD FEMALE |
119 | A CASE OF PULMONARY LANGERHANS CELL HISTIOCYTOSIS DEVELOPED AFTER COMPLETED ANTI-TUBERCULOSIS TREATMENT |
119 | COMPARISON OF TWO NONINVASIVE DEVICES FOR MEASURING RESPIRATORY RATES WITHOUT A FACEMASK DURING WALKING |
119 | NUTRITIONAL STATUS ASSESSMENT OF PULMONARY OUTPATIENTS OF UNIVERSITY OF SANTO TOMAS HOSPITAL |
120 | EFFICACY AND SAFETY OF GLUCOCORTICOIDS IN THE TREATMENT OF SEVERE COMMUNITY-ACQUIRED PNEUMONIA: A META - ANALYSIS |
120 | PULMONARY ANGIOSARCOMA MIMICKING PULMONARY EMBOLISM - A CASE REPORT |
120 | USE OF ACE INHIBITOR AND RISK OF POST-STROKE PNEUMONIA: EVIDENCE-BASED STUDY |
COPD 1 |
121 | LIFE SPACE ACTIVITY IN THE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
121 | A HOME-BASED APPROACH TO BETTER BREATHING IN CANTERBURY - A PILOT STUDY |
121 | POTENTIAL THERAPEUTIC STRATEGY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE USING PIOGLITAZONE AUGMENTED-WHARTON'S JELLY-DERIVED MESENCHYMAL STEM CELLS |
122 | ASSOCIATION BETWEEN SELF-MANAGEMENT BEHAVIOURS OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THE TYPES OF HEALTHCARE SERVICES: CROSS-SECTIONAL QUESTIONNAIRE STUDY |
122 | DIAPHRAGMATIC CONTRACTION DURING HIGH-INTENSITY INSPIRATORY MUSCLE TRAINING IN COPD PATIENTS |
122 | CHRONIC KIDNEY DISEASE LEADS TO ADVERSE CARDIOVASCULAR EVENTS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS USING INHALED LONG-ACTING BRONCHODILATORS |
123 | A STUDY OF THE DETECTION OF ORAL BACTERIA IN COPD PATIENTS |
123 | THE TREND OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ON INTENSIVE CARE UNIT ADMISSION FROM 2003 TO 2013 IN TAIWAN |
123 | CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH THORACIC CAGE REDUCTION UPON MOVEMENT LEADING TO LOW BACK PAIN AND LUMBER HYPEREXTENSION |
124 | IDENTIFICATION OF KEY MODULES AND HUB GENES OF COPD PHENOTYPES WITH WEIGHTED GENE COEXPRESSION NETWORK ANALYSIS |
124 | BACTERIAL COLONIZATION DID NOT AFFECT THE DECLINE OF PULMONARY FUNCTION AMONG BRONCHIECTASIS PATIENTS |
124 | LOW SOCIOECONOMIC STATUS AND INCIDENCE OF AIRWAY OBSTRUCTION IN KOREA:A COMMUNITY-BASED COHORT STUDY |
125 | PATIENTS WITH PULMONARY INFECTIONS AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A RETROSPECTIVE CLINICAL STUDY OF 170 CASES |
125 | ACUPUNCTURE THERAPY FOR ACUTE EXACERBATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A LITERATURE ANALYSIS OF CLINICAL STUDY |
125 | PRODUCTION OF REACTIVE PERSULFIDE SPECIES IN LUNGS OF PATIENTS WITH COPD AND THEIR EFFECTS ON LUNG-RESIDENT CELLS |
126 | SERIAL CHANGES IN EXERCISE CAPACITY, QUALITY OF LIFE AND CARDIOPULMONARY RESPONSES AFTER PULMONARY REHABILITATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
126 | PDPI VERSION OF COPD SCREENING QUESTIONNAIRE VALIDITY AS A SCREENING TOOLS |
127 | EFFICACY AND SAFETY OF HIGH-DOSE BUDESONIDE/FORMOTEROL (320/9 MG) IN PATIENTS WITH BRONCHIOLITIS OBLITERANS SYNDROME AFTER ALLOGENEIC HSCT |
127 | EFFECT OF DAI-KENCHU-TO ON COPD EXACERBATIONS IN ELDERLY PATIENTS: A RETROSPECTIVE STUDY USING A NATIONWIDE DATABASE IN JAPAN |
127 | CORRELATION BETWEEN RESPIRATORY CAPACITY, BODY MASS INDEX, SIX-MINUTES WALKING TEST, RESTING HEART RATE AND SEVERITY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
128 | SAM PROTECTS AGAINST AUTOIMMUNE EMPHYSEMA OF RATS |
128 | RISK FACTORS FOR THE ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
128 | PROGNOSTIC UTILITY OF THE DECAF SCORE TO PREDICT IN-HOSPITAL MORTALITY AMONG PATIENTS WITH ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ADMITTED AT CHINESE GENERAL HOSPITAL |
129 | QUALITY OF LIFE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE BASED ON CLINICAL PHENOTYPES |
129 | BUFEI YISHEN GRANULES SUPPRESS ALVEOLAR EPITHELIAL APOPTOSIS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE RATS: VIA PERK/ EIF2α SIGNALING |
130 | A NEW PARALLEL TWO-STEP ALGORITHM FOR THE TREATMENT OF COPD |
130 | EFFECTIVENESS OF PHARMACEUTICAL CARE ON THE PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ATTENDING A COMMUNITY HOSPITAL IN THAILAND |
130 | EFFECTIVENESS OF A PULMONARY REHABILITATION PROGRAM IN A REHABILITATION HOSPITAL DAY CENTRE FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS FROM PRIMARY CARE CLINICS |
131 | NO2 INHALATION CAUSES IMPAIRED PULMONARY FUNCTION AND HAEMATOLOGICAL DERANGEMENT IN RATS AND INTERVENTION STUDY |
131 | ENVIRONMENTAL FACTORS AND COPD IN THE DEVELOPMENT OF LUNG CANCER |
131 | THE SNP RS61758360 LOCI REDUCING THE RISK OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
132 | GLYCOPYRROLATE IN HIGH-RISK COPD, A DRUG UTILIZATION SURVEILLANCE STUDY IN INDIA (GOAAL): POST-HOC ANALYSES |
132 | STUDY ON THE EFFECTS OF PULMONARY REHABILITATION EXERCISE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN STABLE PERIOD |
132 | COMPOSITE INDEX FOR RECENT MORTALITY IN COPD PATIENTS |
133 | ASSOCIATION OF VITAMIN D3 WITH LUNG FUNCTION AND EXERCISE TOLERANCE IN STABLE COPD PATIENTS: A CROSS-SECTIONAL STUDY |
133 | EFFICACY AND SAFETY OF ONCE-DAILY INHALED UMECLIDINIUM IN ASIAN PATIENTS WITH COPD: RESULTS FROM A RANDOMIZED, PLACEBO-CONTROLLED STUDY |
133 | INVESTIGATION OF FRACTIONAL EXHALED NITRIC OXIDE LEVELS IN THE DIFFERENTIATION OF ASTHMA, COPD AND ASTHMA-COPD OVERLAP |
134 | ANTI-INTERLEUKIN 5 AGENTS IN THE TREATMENT OF EOSINOPHILIC CHRONIC OBSTRUCTIVE PULMONARY DISEASE - A SYSTEMATIC REVIEW AND META-ANALYSIS |
134 | PULMONARY EMPHYSEMA AND LIPID DYSFUNCTION IN MICE LACKING FATTY ACID SYNTHASE IN ALVEOLAR EPITHELIAL CELLS |
134 | A STUDY ON THE PERCEPTION AND REAL WORLD DATA ABOUT LONG TERM OXYGEN THERAPY IN PATIENTS WITH CHRONIC LUNG DISEASES IN KOREA |
135 | METFORMIN USE REVERSES THE ADVERSE PROGNOSTIC EFFECT OF DIABETES MELLITUS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
135 | PRELIMINARY APPLICATION OF INTELLIGENT WRISTBANDS IN COPD PATIENTS |
136 | EFFICACY AND SAFETY OF SWITCH FROM TIOTROPIUM TO INDACATEROL/GLYCOPYRRONIUM IN SYMPTOMATIC MILD-TO-MODERATE COPD PATIENTS FROM KOREA: A RANDOMIZED, OPEN-LABEL, 12-WEEK TRIAL |
136 | NOVEL BENZOXAZIN DERIVATIVE AS NEUTROPHIL ELASTASE INHIBITOR FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
136 | APPRAISAL VALUE OF PERIPHERAL BLOOD EOSINOPHILS IN THE PROGNOSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
137 | ANALYZING PATIENTS' CHARACTERISTICS ASSOCIATED WITH SLEEP DISTURBANCE IN COPD PATIENTS |
137 | A PREDICTION MODEL FOR HOSPITALIZED COPD EXACERBATIONS BASED ON "TREATABLE TRAITS" |
137 | 2 MINUTE WALK TEST AS A SCREENING TOOL FOR COPD |
CRITICAL CARE MEDICINE 1 |
138 | RARE PRESENTATION OF ACUTE B-LYMPHOBLASTIC LEUKAEMIA MIMICS GUILLAIN-BARRE SYNDROME: A CASE REPORT |
138 | PREVENTION AND TREATMENT OF EARLY COMPLICATIONS AFTER DCD LUNG TRANSPLANTATION: A CASE SERIES |
139 | DERIVATION OF WEANSNOW SCORE TO ASSESS THE PROBABILITY OF SUCCESSFUL EXTUBATION AND VENTILATOR LIBERATION: AN ANALYSIS AT THE INTENSIVE CARE UNIT OF A MEDICAL CENTER |
139 | RISK OF RECURRENT RESPIRATORY FAILURE SUBSEQUENT TO SUCCESSFUL WEANING FROM INVASIVE MECHANICAL VENTILATION INITIATED FOR NON-SURGICAL REASONS: A NATIONWIDE COHORT STUDY |
139 | LONG-TERM OUTCOME OF VERY ELDERLY (≥80 YEARS) CRITICAL-ILL PATIENTS IN MEDICAL INTENSIVE CARE UNIT IN A TERTIARY HOSPITAL OF KOREA |
140 | LONG-TERM OUTCOME OF SURVIVORS WITH SEPSIS AFTER INTENSIVE CARE |
140 | DELAYED ADMISSION TO ICU OVER 6 HOURS WAS ASSOCIATED WITH HIGHER HOSPITAL MORTALITY IN PATIENTS WITH SEPSIS |
140 | RISK FACTORS FOR MORTALITY ON PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) IN VIETNAM |
141 | A CALCULOUS CHOLECYSTITIS: A FATAL COMPLICATION IN POST-LUNG TRANSPLANTATION PATIENT – A CASE REPORT |
141 | PREDICTION OF PRONE POSITION VENTILATION RESPONSE FOR ACUTE RESPIRATORY DISTRESS SYNDROME WITH HIGH-RESOLUTION COMPUTED TOMOGRAPHY |
141 | CROSS SECTIONAL PREVALENCE STUDY ON PAEDIATRIC PATIENTS DIAGNOSED WITH SEVERE DENGUE AT A TERTIARY HOSPITAL IN CEBU CITY GIVEN NON INVASIVE VENTILATION VS MECHANICAL INTUBATION |
142 | MIGRATING ORTHOPAEDIC PIN PRESENTING AS HAEMOPTYSIS IN A 10 YEAR OLD MALE: A CASE REPORT |
142 | FACTORS ASSOCIATED WITH POOR OUTCOME IN SEPSIS PATIENTS WITH LIVER CIRRHOSIS |
143 | WEANING PRACTICES AMONG PATIENTS WITH PNEUMONIA ON VENTILATORY SUPPORT AT CHINESE GENERAL HOSPITAL AND MEDICAL CENTER |
143 | NEUTROPHIL-TO-LYMPHOCYTE RATIO AND BLOOD PLATELET COUNT CAN BE PROGNOSTIC MARKERS IN ACUTE RESPIRATORY DISTRESS SYNDROME PATIENTS OF DIFFERENT IMMUNE STATES |
143 | HYPERCAPNIA DURING WEANING FROM PROLONGED VENOVENOUS EXTRACORPOREAL MEMBRANE OXYGENATION IN ACUTE RESPIRATORY DISTRESS SYNDROME |
144 | IMPACT OF PATIENT- AND FAMILY-CENTRED CARE MEETINGS ON INTENSIVE CARE RESOURCE UTILISATION IN TERMINALLY ILL PATIENTS: A SINGLE-CENTRE RETROSPECTIVE OBSERVATIONAL STUDY IN TAIWAN |
144 | FACTORS ASSOCIATED WITH HIGH FLOW OXYGEN THERAPY FAILURE IN ACUTE HYPOXEMIC RESPIRATORY FAILURE PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS |
144 | FIRST CASE OF ACUTE RESPIRATORY DISTRESS SYNDROME AND ALIMENTARY TRACT HAEMORRHAGE FOLLOWING MASS INGESTION OF METHYLISOTHIAZOLINONE |
145 | PHYSICAL FUNCTION AFTER PULMONARY REHABILITATION AS A PREDICTOR OF WEANING SUCCESS AND SHORT-TERM AND MID-TERM SURVIVAL IN PATIENTS REQUIRING PROLONGED MECHANICAL VENTILATION |
145 | AN OPTIMIZING MEDICAL MANAGEMENT FOR ACUTE HYPERCAPNIC RESPIRATORY FAILURE DUE TO ACUTE EXACERBATION COPD |
146 | CLINICAL PARAMETERS AND SERUM BIOMARKER FOR INFLUENCING ICU MORTALITY IN SEVERE SEPSIS PATIENTS |
146 | SINGLE-CENTRE RETROSPECTIVE STUDY OF ADMISSIONS TO THE MEDICAL INTENSIVE CARE UNIT (MICU) AND THE UTILITY OF LACTATE PROCALCITONIN PRODUCT IN PREDICTING MORTALITY |
147 | EXTRACORPOREAL MEMBRANE OXYGENATION APPLICATION IN PREGNANT PATIENT WITH UROSEPSIS ASSOCIATED ACUTE RESPIRATORY DISTRESS SYNDROME – A CASE REPORT |
147 | THE EFFECTIVENESS OF BRONCHOSCOPY IN RESPIRATORY FAILURE PATIENTS |
147 | SEVERE INFLUENZA IN THE INTENSIVE CARE UNITS IN 2018: EXPERIENCE OF A REGIONAL HOSPITAL |
148 | INCIDENCE AND CLINICAL OUTCOMES OF DELIRIUM IN CRITICALLY ILL MEDICAL PATIENTS IN A TERTIARY UNIVERSITY TEACHING HOSPITAL |
148 | DIFFERENT PAO2/FIO2 MEASURING TIME CATEGORIZES DIFFERENT SEVERITY OF LUNG INJURY IN PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME: A PROSPECTIVE STUDY |
148 | COMPARISON OF REINTUBATION RATE AND MORTALITY BY HIGH FLOW NASAL CANNULA AND CONVENTIONAL OXYGEN THERAPY IN POST-EXTUBATION PATIENT :A SYSTEMATIC REVIEW AND META-ANALYSIS |
149 | OUTCOMES OF UNPLANNED EXTUBATION IN ORDINARY WARD ARE SIMILAR TO THOSE IN INTENSIVE CARE UNIT: A RETROSPECTIVE CASE-CONTROL STUDY |
ENVIRONMENTAL & OCCUPATIONAL HEALTH AND EPIDEMIOLOGY 1 |
149 | PARTICULATE MATTER INCREASES EOSINOPHILIC AIRWAY INFLAMMATION |
150 | THE EFFECTS OF AMBIENT FINE PARTICULATES ON 1-YEAR CHANGES OF LUNG FUNCTION AMONG THE ELDERS IN TAIWAN |
150 | AUTOPHAGY INVOLVED OXIDATIVE STRESS INDUCED BY ATMOSPHERIC FINE PARTICLES (PM2.5) IN MOUSE ALVEOLAR MACROPHAGES (MH-S) |
150 | DEVELOPMENT OF COMMUNITY PHARMACY TO THE CENTER OF SMOKING CESSATION, INITIATIVE IN THAILAND |
151 | ROLE OF NRF2 IN LUNG INJURY INDUCED BY DIESEL EXHAUST |
151 | PREVALENCE,RESPIRATORY SYMPTOMS AND RISK OF COPD AMONGPNEUMOCONIOSIS PATIENTS IN CHINA: A CROSS-SECTIONAL STUDY |
151 | PREVALENCE OF RESPIRATORY DISORDERS IN PILGRIMS TRAVELLING TO INDIA FROM CENTRAL SRI LANKA |
152 | SCREENING FOR RESPIRATORY DISEASES AMONG BISCUIT FACTORY EMPLOYEES IN CENTRAL SRI LANKA |
152 | SOCIOLOGIC ASSESSMENT OF THE DEGREE OF APPLICATION OF LUNG FUNCTION EXAMINATION IN PULMONOLOGICAL PRACTICE |
152 | RESOURCES OF PULMONOLOGY ON THE TERRITORY OF THE FAR EAST OF RUSSIA: SOCIAL-ECONOMIC STRATIFICATION AND REGIONAL GRADIENTS |
153 | AGE AND GENDER DISTRIBUTIONS AMONG CHRONIC COUGH PATIENTS IN CHINA: COUGH IS NOT A SIMPLE REFLECTION OF COUGH REFLEX SENSITIVITY |
153 | A CASE STUDY OF SILICOSIS ASSOCIATED PROGRESSIVE MASSIVE FIBROSIS AND SCLERODERMA |
INTERSTITIAL LUNG DISEASE 1 |
154 | BEYOND DEPRESSION AND ANXIETY. A COMPREHENSIVE ASSESSMENT OF THE PSYCHOLOGICAL HEALTH OF PEOPLE DIAGNOSED WITH IPF AND THEIR CAREGIVERS |
154 | DIFFERENCE OF THE CLINICAL CHARACTERISTICS AND OUTCOME BETWEEN CONNECTIVE TISSUE DISEASES ASSOCIATED INTERSTITIAL LUNG DISEASE AND IDIOPATHIC PULMONARY FIBROSIS |
154 | CLINICAL FEATURES OF PATIENTS WITH CLINICALLY AMYOPATHIC DERMATOMYOSITIS WHO HAVE CIRCULATING ANTI-MDA5 AUTOANTIBODIES WITH INTERSTITIAL PNEUMONIA |
155 | FIVE CASES OF ANTI-MDA-5(ANTI-CADM140) POSITIVE CLINICALLY AMYOPATHIC DERMATOMYOSITIS(CADM) WITH INTERSTITIAL PNEUMONIA |
155 | CLINICAL FEATURES AND PROGNOSTIC FACTORS FOR SYSTEMIC SCLEROSIS RELATED INTERSTITIAL LUNG DISEASE |
155 | DIGESTIVE ADVERSE EVENTS FOLLOWING NINTEDANIB ADMINISTRATION IN IDIOPATHIC PULMONARY FIBROSIS |
156 | SERUM SOLUBLE IL-2 RECEPTOR IS A POSSIBLE PROGNOSTIC BIOMARKER IN IDIOPATHIC INTERSTITIAL PNEUMONIA |
156 | PULMONARY LANGERHANS CELL HISTIOCYTOSIS ASSOCIATED WITH SEVERE PULMONARY ARTERIAL HYPERTENSION: REPORT OF A CASE |
157 | MORPHOLOGICAL ANALYSIS OF ALVEOLAR MACROPHAGE IN PATIENTS WITH PULMONARY ALVEOLAR PROTEINOSIS: LET'S REFLECT THE CELL ON A BRONCHOALVEOLAR FLUID SPECIMEN-PART 1 |
157 | THE PREVALENCE OF "CLINICAL PPFE "IN DAILY MEDICAL PRACTICE: TWO YEARS' EXPERIENCE AT A MEDICAL CENTER IN JAPAN |
157 | GOOD LUNG FUNCTION BUT PROGRESSIVE RAYNAUD'S PHENOMENON IN A PATIENT OF SYSTEMIC SCLEROSIS-RELATED INTERSTITIAL LUNG DISEASE AFTER BILATERAL LUNG TRANSPLANTATION |
158 | EXPLORING THE RELATIONSHIP BETWEEN THE PATHOPHYSIOLOGY OF PULMONARY HYPERTENSION (PH) AND THE STATUS OF INTERSTITIAL PNEUMONIA (IP) IN IP-ASSOCIATED PH |
158 | EXTERNAL THERAPY OF TRADITIONAL CHINESE MEDICINE FOR IDIOPATHIC PULMONARY FIBROSIS: A LITERATURE ANALYSIS |
158 | ANALYSIS OF CLINICAL FACTORS DECIDING NECESSITY TO TREAT INTERSTITIAL PNEUMONIAS POSITIVE FOR ANTI-AMINOACYL-TRNA SYNTHETASE ANTIBODIES |
158 | CRYPTOCOCCUS NEOFORMS INDUCED HYPERSENSITIVITY PNEUMONITIS: A CASE REPORT |
159 | BLEOMYCIN-INDUCED IPF MODEL IS ASSOCIATED WITH CELL CYCLE ARREST IN LUNG EPITHELIAL CELL |
159 | THE ROLE OF FOLLOW-UP EVALUATION IN THE DIAGNOSTIC ALGORITHM OF IDIOPATHIC INTERSTITIAL PNEUMONIA: A RETROSPECTIVE STUDY |
160 | INVESTIGATION OF INTRODUCTION OF NINTEDANIB FOR IDIOPATHIC PULMONARY FIBROSIS IN OUR HOSPITAL |
160 | LUNG TRANSPLANT REFERRALS FOR IDIOPATHIC PULMONARY FIBROSIS PATIENTS IN HONG KONG |
160 | RESPIRATORY BRONCHIOLITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (RB-ILD) PRESENTS WITH PROGRESSIVE DYSPNEA - A CASE REPORT |
160 | THIS ABSTRACT HAS BEEN WITHDRAWN |
160 | SAFETY OF NINTEDANIB IN IDIOPATHIC PULMONARY FIBROSIS: A REAL-LIFE STUDY AT OUR HOSPITAL |
161 | REVIEW ANALYSIS FOR CLINICAL CHARACTERISTICS OF INTERSTITIAL LUNG DISEASE ACCOMPANIED WITH LUNG CANCER (ILD-LC) |
161 | SPORADIC LYMPHANGIOLEIOMYOMATOSIS PRESENTING AS SPONTANEOUS PNEUMOTHORAX: A CASE REPORT |
161 | HYALURONAN IN BRONCHOALVEOLAR LAVEGE FLUID FROM PATIENTS WITH AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS |
162 | OBSERVATION ON THERAPEUTIC EFFICACY OF GN-CSF INHALAFION IN PATIENTS WITH RECURRENT PULMONARY ALVEOLAR PROTEINOSIS |
162 | DISEASE ACTIVITY IN AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS ANALYZED BY A MULTIPLEX IMMUNOASSAY SYSTEM |
162 | CASE OF TUBEROUS SCLEROSIS COMPLEX WITH PULMONARY LYMPHANGIOLEIOMYOMATOSIS AND ANGIOMYOLIPOMAS OF THE LIVER AND KIDNEY |
LUNG CANCER 1 |
162 | A CASE OF RESECTED LUNG METASTASIS FROM UTERINE LEIOMYOSARCOMA |
163 | FUCOSYLTRANSFERASE 4 PROMOTES CANCER METASTASIS VIA ENHANCING GLYCOSYLATION OF EGFR/TGFBR SIGNALING NETWORK IN NON-SMALL CELL LUNG CANCER |
163 | EXPERIENCE ON HYPERPROGRESSION DISEASE (HPD) BY IMMUNOTHERAPY FOR LUNG CANCER |
163 | STEREOTACTIC BODY RADIOTHERAPY (SBRT) FOR EARLY STAGE OF NON-SMALL CELL LUNG CANCER: A RETROSPECTIVE, SINGLE-INSTITUTIONAL EXPERIENCE |
164 | PRIMARY THYMIC CARCINOMA, CLEAR CELL TYPE: A CASE REPORT |
164 | PROGNOSTIC EFFECT OF SERUM OXIDATIVE STRESS LEVEL ACCORDING TO SMOKING STATUS IN PATIENTS WITH CURATIVELY RESECTED STAGE I NON-SMALL CELL LUNG CANCER |
165 | THE ROLE OF THE CIRCULATING TUMOR CELLS IN THE SOLITARY PULMONARY NODULES |
165 | A CASE OF OSTEOSARCOMA LUNG METASTASIS WITH LONG-TERM SURVIVAL BY MULTIDISCIPLINARY TREATMENT CENTERED ON MULTIPLE SURGICAL EXCISION |
165 | ADJUVANT CHEMOTHERAPY FOR PATIENTS WITH NON-SMALL CELL LUNG CANCER –EXPERIENCE FROM TAIWAN |
165 | IMMUNOTHERAPY IN NSCLC PATIENTS POSITIVE FOR ANA COULD BE HIGH-RISK AND HIGH-RETURN |
166 | LONG-TERM NICOTINE EXPOSURE IN LUNG CANCER |
166 | RESPIRATORY MUSCLE STRENGTH, EXERCISE CAPACITY, AND DYSPNEA DURING PULMONARY REHABILITATION AFTER LOBECTOMY IN PATIENTS WITH NON-SMALL CELL LUNG CANCER |
166 | THE FREQUENCY OF EGFR MUTATION AND ALK REARRANGEMENT IN PATIENTS WITH LUNG ADENOCARCINOMA: THE EXPERIENCE OF A LOCAL HOSPITAL IN TAIWAN |
167 | RAPID DIAGNOSIS OF THORACIC LYMPH NODE METASTASIS IN PATIENTS WITH LUNG CANCER DURING SURGERY BY DIELECTRIC PROPERTY TEST |
167 | EFFICACY AND SAFETY OF ANTI-PD-L1 ANTIBODY IN NSCLC PATIENTS WHO PREVIOUSLY TREATED WITH ANTI PD-1 ANTIBODIES: PRELIMINARY STUDY |
167 | A COMPREHENSIVE ANALYSIS OF PD-L1 EXPRESSION IN LUNG CANCER PATIENTS: WITH EMPHASIS ON THE IMPACT OF ARCHIVAL TISSUE |
168 | THE INCIDENCE OF EGFR MUTATIONS IN PATIENTS WITH ADENOCARCINOMA |
168 | EFFECTIVENESS OF TREATMENTS IN ADVANCED NON-SMALL CELL LUNG CANCER WITH EXON 20 INSERTION EPIDERMAL GROWTH FACTOR RECEPTOR MUTATIONS |
168 | MICRORNA EXPRESSION PROFILING FOR IDENTIFYING MALIGNANT PLEURAL EFFUSION IN PATIENTS WITH LUNG ADENOCARCINOMA |
168 | TEXTURE ANALYSIS PREDICTING EGFR MUTATION AND RECURRENCE IN LUNG ADENOCARCINOMA |
169 | DIFFERENCES OF CLINICAL FEATURES BASED ON PD-L1 EXPRESSION IN JAPANESE LUNG CANCER PATIENTS |
169 | NON-SMALL CELL CARCINOMA OF THE LUNG INITIALLY PRESENTING AS LUNG ABSCESS |
169 | OSIMERTINIB COMBINED WITH CETUXIMAB FOR NON-SMALL CELL LUNG CANCER (NSCLC) WITH T790M AND C797S MUTATIONS |
170 | NO TIME TO LOSE- UNDERSTANDING HOW VARIATION IN PRACTICE AFFECTS LENGTH OF STAY FOR PATIENTS WITH MALIGNANT PLEURAL EFFUSION |
170 | DNA DEMETHYLATING AGENTS SENSITIZE IMMUNE-BASED CYTOTOXICITY BY UPREGULATING IMMUNE SYNAPSE MOLECULES ON LUNG CANCER CELLS |
171 | A CASE OF PSEUDOMESOTHELIOMATOUS LUNG CANCER IN PATIENT WITHOUT EXPOSURE TO ASBESTOS |
171 | METFORMIN PROLONGS SURVIVAL IN LUNG CANCER EGFR-TKIS PATIENTS |
171 | NORTHERN MALAYSIA PULMONOLOGY CENTRE EXPERIENCE AND ANALYSIS OF PROGRESSION FREE SURVIVAL RATE WITH TYROSINE KINASE INHIBITORS IN MANAGING ADVANCED ADENOCARCINOMA OF LUNG |
172 | AN IMMUNE PROFILE OF TUMOR PD-L1 EXPRESSION PLUS CD4 OR CD8 T CELL INFILTRATIONS CORRELATED WITH TREATMENT EFFICACY OF PD-1 BLOCKADE ANTIBODIES IN NSCLC PATIENTS |
172 | SMALL CELL LUNG CANCER TRANSFORMATION AND T790M MUTATION COEXISTING AFTER SUBSEQUENT FIRST AND THIRD GENERATION EGFR-TKI THERAPY: A RARE CASE REPORT AND LITERATURE REVIEW |
173 | PULMONARY SCLEROSING PNEUMOCYTOMA IN AN ASYMPTOMATIC YOUNG ASIAN MAN: A CLINICOPATHOLOGIC CASE REPORT |
173 | LUNG CANCER WITH SMALL BOWEL METASTASIS AND PERFORATION WITH CHEMOTHERAPY-NAÏVE STATUS, A RARE CASE REPORT AND LITERATURE VIEW |
174 | CHYLOTHORAX IN MEDIASTINAL TUMOR |
174 | ADVANCED NON-SMALL CELL LUNG CANCER WITH TONSIL METASTASIS, A CASE REPORT |
174 | ADENYLATE CYCLASE-ASSOCIATED PROTEIN 1-TARGETED NANOPARTICLES AS A NOVEL STRATEGY FOR THE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER |
175 | A 3-YEAR STUDY ON THE INCIDENCE AND PREDICTORS OF EARLY COMPLICATIONS RESULTING FROM CT-GUIDED TRANSTHORACIC BIOPSY AT THE LUNG CENTER OF THE PHILIPPINES |
175 | IMPACT OF ELDERLY ON ONE YEARS SURVIVAL RATES OF PATIENTS WITH NON SMALL CELL LUNG CANCER |
175 | A CASE OF MALIGNANT PLEURAL MESOTHELIOMA THAT COMPLICATED WITH PERITONEAL DISSEMINATION DURING THE 10-YEAR SURVIVAL |
176 | DISCOVERY THE NOVEL COMPOUND FOR OVERCOMING EGFR-TKI RESISTANCE IN LUNG ADENOCARCINOMA |
176 | COMPARABILITY OF AUTOMATED IMAGE CYTOMETRY RESULTS OF BRONCHIAL WASHINGS WITH MANUAL CYTOLOGY AND HISTOPATHOLOGY IN DIAGNOSIS OF LUNG CANCER AT LUNG CENTER OF THE PHILIPPINES |
177 | MULTIPLE PRIMARY LUNG CANCER OR RELAPSE? A REPORT OF TWO CASES |
177 | THE RISK OF MECHANICAL VENTILATION IN PATIENTS WITH LUNG CANCER AT END-OF LIFE IN TAIWAN |
177 | NIVOLUMAB-INDUCED SEVERE ACUTE KIDNEY INJURY WITH A LONG LATENT PHASE IN A PATIENT WITH NON-SMALL CELL LUNG CANCER: A CASE REPORT |
178 | RISK FACTORS OF LUNG CANCER IN MALE NEVER-SMOKERS IN PERSAHABTAN NATIONAL HOSPITAL |
178 | MOLECULAR BIOLOGICAL ANALYSIS IN A PATIENT WITH MULTIPLE LUNG ADENOCARCINOMA |
PAEDIATRIC LUNG DISEASE 1 |
178 | THERAPEUTIC EFFECT OF LEUKOTRIENE RECEPTOR ANTAGONIST MONTELUKAST IN TREATMENT OF RESPIRATORY TRACT MYCOPLASMAL INFECTIONS IN CHILDREN |
179 | THIS ABSTRACT HAS BEEN WITHDRAWN |
179 | AN UNEXPECTED FINDING OF PERSISTENT RIGHT LUNG COLLAPSE; CHILDHOOD ENDOBRONCHIAL TUMOUR: A CASE REPORT |
179 | MASSIVE HAEMOPTYSIS IN CHILDREN DUE TO INTRALOBAR PULMONARY SEQUESTRATION (CASE REPORT) |
179 | PULMONARY INTRALOBAR SEQUESTRATION WITH CONGENITAL PULMONARY AIRWAY MALFORMATION TYPE II (CPAM TYPE II) |
PULMONARY CIRCULATION 1 |
180 | PULMONARY ARTERIOVENOUS MALFORMATION PRESENTING AS RECURRENT ISCHEMIC STROKE: A CASE REPORT |
180 | RISK OF SYMPTOMATIC VENOUS THROMBOEMBOLISM IN PATIENTS FOLLOWING APPENDECTOMY: A NATIONWIDE COHORT STUDY |
180 | HAEMOPTYSIS DUE TO A RARE CAUSE IN THREE PATIENTS FROM CENTRAL SRI LANKA |
181 | AIR-CRESCENT IS NOT ALWAYS INFECTIOUS EVENT |
181 | PATHWAYS HSA_CIRC_0026480–MIR-27A-3P–ATXN1 AND HSA_CIRC_0046159–MIR-1226-3P–ATP2A2 ARE INVOLVED IN THE DEVELOPMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION |
RESPIRATORY INFECTIONS (NON-TUBERCULOUS) 1 |
182 | THE PHYSICIAN'S PERSPECTIVES ON THE DEFINITION, CLINICAL PRACTICES AND CLINICALLY IMPORTANT OUTCOMES IN THE MANAGEMENT OF ACUTE BRONCHIOLITIS IN THE TERTIARY HOSPITALS OF CEBU CITY, PHILIPPINES |
183 | DIAGNOSTIC PREDICTIVE FACTOR OF ADENOVIRAL PNEUMONIA IN PATIENTS ADMITTED FOR COMMUNITY-ACQUIRED PNEUMONIA IN Republic of Korea MILITARY TRAINEES |
183 | CT-GUIDED DRAINAGE FOR LUNG ABSCESS |
183 | PROGRESSIVE DISSEMINATED HISTOPLASMOSIS DERIVED FROM ACUTE PULMONARY HISTOPLASMOSIS IN A 61-YEAR-OLD MALE IN NORTH-WESTERN CHINA: A CASE REPORT AND REVIEW OF LITERATURE |
184 | CLINICAL SIGNIFICANCE OF SERUM PRESEPSIN LEVEL IN HOSPITALIZED PNEUMONIA |
184 | INFLAMMATORY TRACHEOBRONCHITIS: A RARE PRESENTATION OF PSEUDOMONAS AERUGINOSA INFECTION |
184 | TRANSBRONCHIAL INSTILLATION OF LIPOSOMAL AMPHOTERICIN B: TOPICAL THERAPY FOR CHRONIC PROGRESSIVE PULMONARY ASPERGILLOSIS |
185 | TANREQING INJECTION FOR BRONCHIECTASIS: A SYSTEMATIC REVIEW AND META-ANALYSIS |
185 | RETROSPECTIVE ANALYSIS OF SURGERY FOR THE MANAGEMENT OF PARAPNEUMONIC PLEURAL EFFUSION AND ACUTE EMPYEMA |
186 | PULMONARY INFECTIONS IN POST-LUNG TRANSPLANTATION PATIENTS: CASE SERIES OF A TERTIARY MEDICAL CENTER IN TAIWAN |
186 | MULTICENTER SURVEY OF POST-INFLUENZA RESPIRATORY COMPLICATIONS IN THE SEASON BETWEEN 2017 AND 2018 IN TOKYO CENTRAL AREA |
186 | FREQUENT EMPIRIC BROAD-SPECTRUM ANTIMICROBIAL USE AMONG HOSPITALIZED PATIENTS WITH LOWER RESPIRATORY TRACT INFECTION IN SOUTHERN SRI LANKA |
187 | ROLE OF BRONCHOSCOPY FOR PATHOGEN DIFFERENTIATION IN PATIENTS WITH EMPYEMA |
187 | RISK FACTORS OF DISCONTINUATION OF MULTIPLE DRUGS TREATMENT OF MAC LUNG DISEASE |
187 | UTILIZATION OF PROCALCITONIN AS A DIAGNOSTIC BIOMARKER OF PEDIATRIC VENTILATOR-ASSOCIATED PNEUMONIA IN PATIENTS WITH CONGENITAL HEART DISEASE FOLLOWING CARDIAC SURGERY |
188 | SINGLE-TROCAR VIDEO-ASSISTED FLEXIBLE THORACOSCOPIC DEBRIDEMENT UNDER LOCAL ANAESTHESIA FOR MULTILOCULATED PARAPNEUMONIC EMPYEMA |
188 | URINARY ANTIGEN TESTING IN COMMUNITY-ACQUIRED PNEUMONIA: CLINICAL UTILITY, COST EFFECTIVENESS AND THE IMPACT ON ANTIBIOTIC TREATMENT |
189 | EFFICACY OF CORTICOSTEROID ADMINISTRATION IN SEVERE COMMUNITY-ONSET PNEUMONIA PATIENTS: USING THE JAPANESE DIAGNOSTIC PROCEDURE COMBINATION DATABASE |
189 | RISK FACTORS AND IMPLICATIONS FOR READMISSION OF PATIENTS FOLLOWING HOSPITALIZATION FOR COMMUNITY-ACQUIRED PNEUMONIA IN Republic of Korea |
189 | RARE PRESENTATION OF HYDATID CYST |
190 | A CASE OF PRIMARY MEDIASTINAL ACTINOMYCOSIS PRESENTED WITH RECURRENT LYMPHOCYTE-PREDOMINANT PLEURAL EFFUSION |
190 | EFFECTS OF INTRAVENA N-ACETYLCYSTEIN ON NEUTROPHIL, PROCALCITONIN, C REACTIVE PROTEIN AND LENGTH OF CLININICAL IMPROVEMENT IN COMMUNITY ACQUIRED PNEUMONIA |
191 | CHARACTERISTICS OF PATIENTS WITH HIGH MYCOBACTERIUM-AVIUM COMPLEX ANTIBODY |
191 | IFN-γ RESPONSE TO PPD STIMULATION IN NON-TUBERCULOUS MYCOBACTERIAL PATIENTS MAY DISTINGUISH ACTIVE STAGE FROM CHRONIC ONE |
191 | RETROSPECTIVE ANALYZE THE CLINICAL APPLICATION OF CRYPTOCOCCAL ANTIGEN (COLLOIDAL GOLD METHOD) TO DETECT PULMONARY CRYPTOCOCCOSIS |
192 | PNEUMONIA IN EARLY POST-KIDNEY TRANSPLANT PERIOD; A RETROSPECTIVE COHORT STUDY |
192 | PULMONARY NOCARDIA INFECTION PRESENTING AS MULTIPLE LUNG MASSES |
192 | KARTAGENER'S SYNDROME: A RARE CASE REPORT IN MALE |
193 | CLINICAL EFFICACY AND COST-EFFECTIVENESS ANALYSIS OF CEFEPIME OR PIPERACILLIN/TAZOBACTAM BOTH WITH CIPROFLOXACIN IN MICU PATIENTS WITH SEVERE PNEUMONIA |
193 | IMPORTANCE AND EFFICACY OF CONCURRENT INTRAVENOUS COLISTIN WITH NEBULIZED COLISTIN FOR VENTILATOR-ASSOCIATED PNEUMONIA COMPARED WITH ONLY INTRAVENOUS COLISTIN |
193 | THE EFFECT OF PROCALCITONIN-GUIDED THERAPY ON PRESCRIPTION AND DURATION OF ANTIBIOTICS AMONG PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA: A META-ANALYSIS |
RESPIRATORY NEUROBIOLOGY AND SLEEP 1 |
194 | A CASE REPORT ON BILATERAL DIAPHRAGMATIC DYSFUNCTION DUE TO BILATERAL PHRENIC NERVE NEUROPATHY IN A 65-YEAR-OLD MALE WITH DYSPNEA ON SUPINE POSITION |
194 | ABERRANT DNA METHYLATION LEVELS OF THE FORMYL PEPTIDE RECEPTOR 1/2/3 GENE PROMOTER REGIONS ARE ASSOCIATED WITH OBSTRUCTIVE SLEEP APNOEA |
195 | USING NOSAS SCORE TO PREDICT SEVERE OBSTRUCTIVE SLEEP APNEA IN A CLINIC-BASED POPULATION |
195 | TOO LITTLE O2, TOO MUCH HGB |
196 | CPAP ADHERENCE IN ADULTS WITH NEWLY DIAGNOSED OSAHS AND RELATED INFLUENTIAL FACTORS: A STUDY IN CHANGSHA, CHINA |
196 | HOW DOES THE OBSTRUCTIVE SLEEP APNEA INFLUENCE THE SLEEP EFFICIENCY, SLEEPINESS, AND NEUROCOGNITIVE FUNCTION IN PATIENTS WITH REM SLEEP BEHAVIOUR DISORDER |
197 | RETROSPECTIVE OBSERVATIONAL STUDY OF OBSTRUCTIVE SLEEP APNOEA IN WOMEN IN NORTHERN TERRITORY AUSTRALIA |
197 | THE USE OF CONTINUOUS PULSE OXIMETRY IN THE DIAGNOSIS OF DEVENTILATION SYNDROME IN A CASE OF KYPHOSCOLIOSIS WITH CHRONIC VENTILATORY FAILURE |
197 | DYSPNEA IMPROVEMENT IN PATIENTS WITH LUNG DISEASES IN A SINGLE SESSION OF MINDFUL BREATHING: A RANDOMIZED CONTROLLED STUDY |
198 | TREATMENT EMERGENT SLEEP APNEA: A CASE REPORT |
RESPIRATORY STRUCTURE AND FUNCTION 1 |
198 | NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND RESPIRATORY FUNCTIONS |
198 | THE WEIGHT LOSS THERAPY IMPROVED RESPIRATORY FUNCTION AND RESPIRATORY SYSTEM IMPEDANCE IN OBESE SUBJECTS |
199 | PRIMARY MEDIASTINAL SEMINOMA PRESENTING AS SUPERIOR VENA CAVA SYNDROME: A CASE REPORT |
199 | THE CORRELATION BETWEEN RESPIRATORY FUNCTION AND GAIT ASYMMETRY IN STROKE PATIENTS |
199 | LEFT BRONCHIAL ISOMERISM PRESENTED AS A SEVERE OBSTRUCTIVE VENTILATORY DISTURBANCE IN A HEALTHY ADULT |
200 | RELATIONSHIP BETWEEN LOW-FREQUENCY INTERVENTION FOR INSPIRATORY MUSCLE TRAINING AND COUGH PEAK FLOW IN HEALTHY YOUNG ADULTS |
200 | DECLINE IN LUNG FUNCTION IS ASSOCIATED WITH ELEVATED LIPOPROTEIN A LEVELS IN KOREAN HEALTH SCREENING SUBJECTS WITHOUT CLINICALLY APPARENT DISEASE: A CROSS-SECTIONAL STUDY |
200 | TRAUMATIC CHYLOTHORAX IN YOUNG CHILDREN: CASE SERIES AND MANAGEMENT |
201 | COMPARISON OF THE EFFICIENCY OF ORAL AIRWAY AND NASAL AIRWAY INSERTED IN THE ORAL AIRWAY DURING MASK VENTILATION |
TUBERCULOSIS 1 |
201 | IMPACT OF ADDITIONAL ANTIBIOTICS ON IN-HOSPITAL MORTALITY IN PULMONARY TUBERCULOSIS COMPLICATED BY BACTERIAL PNEUMONIA: A PROPENSITY SCORE ANALYSIS |
201 | A NOVEL COMBINATIVE ADJUNCT THERAPY TARGETING HOST NUCLEAR RECEPTORS MINIMIZES TUBERCULOSIS TREATMENT REGIMEN |
202 | PROFOUND CD4 LYMPHOPENIA IN A NON HIV PATIENT WITHMILIARY TUBERCULOSIS, PRESENTING WITH AN AIDS DEFINING INFECTION |
202 | THE PROGNOSTIC FACTORS AMONG ELDERLY PATIENTS WITH LUNG TUBERCULOSIS: A COMPETING RISK ANALYSIS |
203 | CORRELATION BETWEEN RADIOLOGIC ACTIVITIES ON CHEST CT WITH MICROBIOLOGIC RESULTS VIA BRONCHOSCOPY IN PULMONARY TUBERCULOSIS |
203 | THE CORRELATION BETWEEN INTERFERON-γ AND INTERLEUKIN-17 LEVELS TO THE CHEST RADIOGRAPHIC INTERPRETATION IN RIFAMPICIN-RESISTANCE AND RIFAMPICIN-SENSITIVE PULMONARY TUBERCULOSIS |
204 | CLINICAL OUTCOMES OF TAILORED VS STANDARD ANTI-TUBERCULOSIS THERAPY IN PATIENTS WITH TUBERCULOUS LYMPHADENITIS |
204 | NEUTROPHIL-LYMPHOCYTE COUNT RATIO (NLR) WAS ASSOCIATED WITH DISEASE ACTIVITY IN TUBERCULOSIS AND DIABETIC MELLITUS PATIENTS |
204 | THE COMPLIANCE AND SIDE EFFECTS OF 3HR THERAPY IN LATENT TUBERCULOSIS INFECTION |
205 | CORTICOSTEROIDS FOR MANAGING TUBERCULOUS SEROSITIS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS |
205 | IMPACT OF non-tuberculous MYCOBACTERIA COLONIZATION OR INFECTION ON MULTIDRUG RESISTANCE TUBERCULOSIS TREATMENT |
205 | EXTRA PULMONARY TUBERCULOSIS IN HIV PATIENTS:PROFILE & OUTCOME OF PATIENTS AT WESTERN VISAYASMEDICAL CENTER PPMD DOTS UNIT PHILIPPINESJANUARY 2015 TO JUNE 2018 |
206 | A CASE OF TUBERCULOUS SPONDYLITIS FOLLOWING INTRAVESICAL BCG THERAPY |
206 | PERFORMANCE OF GENEXPERT MTB/RIF ASSAY IN PULMONARY AND EXTRAPULMONARY SAMPLES IN REAL WORLD SETTING |
206 | LOW INCIDENCE OF DRUG INDUCED HEPATITIS IN 4 MONTHS RIFAMPICIN REGIMEN FOR THE PREVENTIVE CHEMOTHERAPY OF LATENT TUBERCULOSIS INFECTION |
207 | CLINICAL DIFFERENCES BETWEEN POSITIVE AFB AND NEGATIVE AFB IN LUNG TUBERCULOSIS PATIENTS IN INDONESIA |
207 | KNOWLEDGE, ATTITUDES AND PRACTICES REGARDING PULMONARY TUBERCULOSIS AMONG HIGH RISK HEALTH CARE WORKERS IN UST HOSPITAL |
207 | CHARACTERISTICS OF TUBERCULOSIS PATIENTS WITH AFB SPUTUM SMEAR EXAMINATION POSITIVE AT PULMONARY HEALTH CENTER (BALAI KESEHATAN PARU MASYARAKAT) IN BANYUMAS, CENTRAL JAVA, INDONESIA |
208 | A CROSS-SECTIONAL STUDY TO PROFILE NON-CYSTIC FIBROSIS BRONCHIECTASIS IN MALAYSIA |
208 | FACTORS PREDICTING THE NEED OF INTENSIVE CARE IN PATIENTS WHO WERE ADMITTED FOR PULMONARY TUBERCULOSIS |
208 | ELIGIBILITY OF SHORTER REGIMEN (STR) AMONG MULTIDRUG RESISTANT TUBERCULOSIS PATIENTS IN PERSAHABATAN HOSPITAL, INDONESIA |
209 | ACQUIRED BRONCHOESOPHAGEAL FISTULA IN ADULT FILIPINO |
209 | SOLITARY PULMONARY NODULES DUE TO NON-TUBERCULOUS MYCOBACTERIAL INFECTION DIAGNOSED WITH VIDEO-ASSISTED THORACOSCOPIC SURGERY |
210 | LATENT TUBERCULOSIS INFECTION AND TREATMENT STATUS OF NORTH KOREAN REFUGEES |
210 | PRIMARY MDR TB CASES IN WEST SUMATERA |
ASTHMA 2 |
211 | DEVELOPMENT OF A COST-EFFECTIVENESS MODEL TO ASSESS ASTHMA INHALER ADHERENCE AND TECHNIQUE INTERVENTIONS |
211 | IMPACT OF OMALIZUMAB IN TREATMENT OF SEVERE ALLERGIC ASTHMA: PERSPECTIVE FROM SINGLE CENTER EXPERIENCE IN MALAYSIA |
211 | PRODUCTION OF REACTIVE NITROGEN SPECIES IN ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP |
212 | TRIMETHYLAMINE-N-OXIDE REVERSES AUTOPHAGIC DYSFUNCTION IN THE LUNG TISSUES OF OVA-OVA BRONCHIAL ASTHMA MICE |
212 | THE CONDITION OF LUNG FUNCTION IN PATIENTS WITH ASTHMA DEPENDING ON THE BODY MASS |
212 | FACTORS ASSOCIATED WITH EFFICACY OF TIOTROPIUM IN PATIENTS WITH ASTHMA |
213 | BRONCHIAL THERMOPLASTY SUCCESS IN ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP: A CASE REPORT |
213 | THE EFFICACY OF A STRUCTURED ASTHMA DISEASE MANAGEMENT PROGRAM IMPACTS ON OVERALL CONTROL OF ASTHMA & QUALITY OF LIFE OF ASTHMA PATIENTS |
213 | PHYSICIANS' PERCEPTION ON PATTERNS OF DIAGNOSING AND MANAGING ASTHMA: A SURVEY IN MYANMAR |
213 | THE POTENTIAL ROLE OF SERUM TGF-β AS A BIOMARKER FOR ASTHMA |
214 | NOVEL ASSOCIATION BETWEEN ASTHMA AND OSTEOARTHRITIS |
214 | A COMPLIANCE STUDY OF THE MANAGEMENT OF PATIENTS WITH ASTHMA AGAINST THE GLOBAL INITIATIVE FOR ASTHMA (GINA) GUIDELINES 2016 |
214 | NEUTROPHILIC INFLAMMATION OF THE UPPER AIRWAYS IS A CHARACTERISTIC FEATURE OF MACROLIDE RESPONDERS IN PATIENTS WITH ASTHMA |
215 | THE ASTHMA EXACERBATION AFTER INHALED CORTICOSTEROID WITHDRAWAL: THE ANALYSES OF THE NATIONAL HEALTH INSURANCE DATABASE |
215 | ASSESSMENT OF THE ACTUAL CONDITION OF ELDERLY ASTHMA |
215 | THE SITUATION OF SERVICE IN PATIENT WITH ASTHMA EXACERBATION, EXPERIENCE IN SECONDARY CARE HOSPITAL, THAILAND |
216 | BITTER TASTE RECEPTOR AND ITS ROLE OF RELIEVING BRONCHOSPASM FOR THE ASTHMATICS- AN EVIDENCE-BASED MEDICINE UPDATE, 2018 |
216 | THE CHANGE OF NASAL RESISTANCE AT THE ACUTE NASAL CHALLENGE WITH COLD AIR IN ASTHMATICS WITH COLD AIRWAY HYPERRESPONSIVENESS |
216 | POLY-UNSATURATED FATTY ACIDS METABOLOMICS STUDY REVEALS CHILDHOOD SERUM HETES LEVELS CLOSELY RELATED TO GLUTATHIONE PEROXIDASES IN ALLERGIC ASTHMA |
217 | RESOLVIN E3 ATTENUATES ASTHMATIC INFLAMMATION IN A MURINE MODEL OF HOUSE DUST MITE (HDM) -INDUCED AIRWAY INFLAMMATION |
217 | EFFECT OF NEBULIZED INHALED TRIPTOLIDE IN MOUSE MODEL OF ASTHMA |
217 | VALIDATION OF RISK FACTORS OF ASTHMA ATTACK QUESTIONNAIRE AMONG MALAYSIAN ADULT ASTHMATIC PATIENTS |
218 | THE DIFFERENT RELATIONSHIP IN SINGLE NUCLEOTIDE POLYMORPHISMS OF CHITINASE 3-LIKE 1 (CHI3L1) GENE, CHI3L1 SERUM LEVEL, WITH BRONCHIAL ASTHMA AND ALLERGIC RHINITIS IN TAIWAN |
218 | EFFECTIVENESS OF A LONG-TERM COMBINED THERAPY IN PATIENTS WITH PERSISTENT ASTHMA DEPENDS ON THE PATTERN OF INFLAMMATION AND AIRWAY RESPONSE TO COLD AIR |
218 | THE CORRELATION OF AIRWAY RESPONSES TO OSMOTIC AND THERMAL STIMULI IN ASTHMATICS WITH EXERCISE-INDUCED BRONCHOCONSTRICTION |
219 | THE FIRST EQUATION TO ESTIMATE THE SIX-MINUTE WALK DISTANCE IN HEALTHY MALAYSIAN ADULT AGED 20 TO 40 YEARS OLD |
BRONCHOSCOPY AND INTERVENTIONAL TECHNIQUES 2 |
219 | COMPARISON OF RADIAL PROBE ENDOBRONCHIAL ULTRASOUND GUIDED AND BLIND TRANSBRONCHIAL LUNG BIOPSY IN DIFFUSE LUNG LESIONS |
219 | ANALYSES OF LUNG SOUNDS BEFORE AND AFTER THE TREATMENTS FOR LARGE AIRWAY STENOSIS |
220 | RIGHT MAIN BRONCHIAL PLEOMORPHIC ADENOMA: A RARE CASE REPORT AND LITERATURES REVIEW |
220 | BRONCHOSCOPIC THERMAL VAPOUR ABLATION (BTVA) FOR SEVERE EMPHYSEMA: PRELIMINARY EXPERIENCE WITH A NOVEL INTERVAPOR® TECHNOLOGY IN A SINGAPORE TERTIARY HOSPITAL |
221 | EFFICACY AND INFLUENCE FACTORS OF INTERVENTIONAL BRONCHOSCOPY FOR THE TREATMENT OF SCARRING AIRWAY STENOSIS |
221 | FEASIBILITY OF RE-BIOPSY BY ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL ASPIRATION (EBUS-TBNA) IN PATIENTS WITH PREVIOUSLY TREATED LUNG CANCER |
221 | TRACHEAL STENOSIS IN A YOUNG LADY FOLLOWING SHORT-TERM INTUBATION: MIMICKING ASTHMA |
222 | COMPARISON OF DEXMEDETOMIDINE TO PROPOFOL FOR SEDATION OF ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION: A RANDOMIZED CONTROLLED TRIAL |
222 | DIAGNOSIS OF PULMONARY FUNGUS BALL USING ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE ASPIRATION: CASE REPORTS |
222 | A CASE OF TRACHEOBRONCHOPATHIA OSTEOCHONDROPLASTICA OBSERVED ON ENDOBRONCHIAL ULTRASOUND |
223 | DIAGNOSTIC YIELD AND SAFETY OF EBUS-TBNA AND PERIPHERAL EBUS GUIDED TBLB UNDER MODERATE SEDATION: A SINGLE-CENTER RETROSPECTIVE AUDIT |
223 | ENDOBRONCHIAL TREATMENT OF BRONCHOPLEURAL FISTULAS BY USING OVAL FORAMEN OCCLUDER UNDER VIRTUAL BRONCHOSCOPIC NAVIGATION: A CASE |
224 | PSEUDO-MEIGS' S SYDROME: CASE REPORT |
224 | CLINICAL IMPACT OF A NEW 25 GAUGE ENDOBRONCHIAL ULTRASOUND-GUIDED TRANSBRONCHIAL NEEDLE IN LYMPH NODE STAGING |
225 | REMOVAL OF THE HIGH-RISK BRONCHIAL OSSEOUS FOREIGN BODY UNDER VIRTUAL BRONCHOSCOPE NAVIGATION AND FORMULATION |
225 | THE USEFULNESS OF PLEURAL BIOPSY IN PLEURAL EFFUSION |
225 | A NEW TECHNIQUE FOR SELF-EXPANDING METALLIC Y-SHAPED AIRWAY STENTS DEPLOYMENT, SAFE AND SIMPLE |
226 | TRANSBRONCHIAL CRYOBIOPSY IN DIFFUSE PARENCHYMAL LUNG DISEASE: A CHINESE PERSPECTIVE |
226 | NOVEL USE OF SPYSCOPE FOR PLACEMENT OF CATHETER IN RIGHT UPPER LOBE TO CONTROL BLEEDING DURING CRYOBIOPSY |
226 | TWO YEARS EXPERIENCE OF INDWELLING PLEURAL CATHETER PLACEMENT FOR MALIGNANT AND RECURRENT PLEURAL EFFUSION IN SONGKLANAGARIND HOSPITAL |
227 | DIAGNOSING MALIGNANCIES IN THE LUNG: THE QUALITY OF A BRONCHOSCOPY SERVICE AT A TERTIARY HOSPITAL |
227 | BRONCHIAL LEIOMYOMA: A RARE BRONCHIAL TUMOR WITH UNCOMMON PRESENTATION OF RECURRENT HAEMOPTYSIS |
227 | DIAGNOSTIC VALUE OF THORACOSCOPE FOR PLEURAL DISEASES IN INTERNAL MEDICINE |
228 | CONCURRENT PROCEDURE OF PRIMARY TUMOUR BIOPSY USING NAVIGATIONAL EBUS BRONCHOSCOPY AND LYMPH NODE STAGE USING EBUS-TBNA IN LUNG CANCER PATIENTS WITH PERIPHERAL AND MEDIASTINAL LESIONS |
228 | AETIOLOGY AND MANAGEMENT OF 131 PATIENTS WITH MAIN TRACHEAL STENOSIS |
CELL AND MOLECULAR BIOLOGY 2 |
228 | VITEXIN MAY EXERTS ANTI-ALLERGIC INFLAMMATORY EFFECTS VIA ORAI1 CHANNEL INHIBITION |
229 | INHIBITION OF NKCC1 MODULATES INFLAMMATION AND APOPTOSIS OF ALVEOLAR EPITHELIUM IN ISCHEMIA-REPERFUSION LUNG INJURY VIA NF-KB AND P38 MAPK PATHWAYS |
229 | ASSOCIATION BETWEEN CIGARETTE SMOKING STATUS AND COMPOSITION OF GUT MICROBIOTA IN KOREAN MEN |
229 | THE ROLE OF SODIUM-POTASSIUM-CHLORIDE COTRANSPORTER IN LPS-INDUCED ALVEOLAR MACROPHAGE ACTIVATION |
230 | THE HYPOXIA-INDUCIBLE FACTOR 1α PROTEIN STABILIZER INHIBITS TRANSFORMING GROWTH FACTOR β-INDUCED EXTRACELLULAR MATRIX PROTEINS BEYOND CELL TYPES AND SPECIES |
230 | HETERONEMIN INDUCES ROS-BASED MITOCHONDRIAL-MEDIATED APOPTOSIS IN LUNG CANCER CELLS |
CLINICAL ALLERGY AND IMMUNOLOGY 2 |
230 | BRONCHOSCOPIC FEATURES OF RELAPSING POLYCHONDRITIS OF LARGE AIRWAYS AFTER TRACHEOSTOMY |
231 | ONE-YEAR FOLLOW-UP STUDY OF PHARMACOKINETIC INTERACTIONS IN A TACROLIMUS-TREATED LUNG TRANSLPLANT PATIENT |
231 | ASIA-PACIFIC SURVEY OF PHYSICIANS ON ASTHMA AND ALLERGIC RHINITIS (ASPAIR) – INDIA RESULTS |
232 | METABOLOMIC PROFILING OF SERUM DURING ALLERGEN IMMUNOTHERAPY IN ASTHMATIC CHILDREN |
CLINICAL RESPIRATORY MEDICINE 2 |
232 | THE ROLE OF HIGH ALTITUDE SIMULATION TEST (HAST) IN PATIENTS WITH PULMONARY DISEASE AND NORMAL OXYGEN SATURATION AT BASELINE |
232 | HIGH ATTENUATION AREA ALONG THE BRONCHIAL WALL ON COMPUTED TOMOGRAPHY SUGGESTS THE IRON PILL ASPIRATION |
233 | ACCURACY OF A SONOGRAPHIC SCORING INDEX IN THE CLASSIFICATION OF PLEURAL EFFUSION |
233 | NIPPV (NON INVASIVE POSITIVE PRESSURE VENTILATION) CAN IMPROVE THE CLINICAL OUTCOMES OF THORACIC SURGERY PATIENTS |
233 | IMPROVEMENT QUALITY OF LIFE IN MEDIASTINAL SOLITARY FIBROUS TUMOR PATIENT: CHEMOTHERAPY PALLIATIVE PERSPECTIVE |
234 | THE ROLE OF IMMUNOHISTOCHEMISTRY IN A MALIGNANT PLEURAL EFFUSION FROM AN OCCULT PAPILLARY THYROID CARCINOMA: A CASE REPORT |
234 | SUCCESSFUL MANAGEMENT OF LEPTOSPIROSIS ASSOCIATED DIFFUSE ALVEOLAR HEMORRHAGE USING AN EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) |
234 | RESPIRATORY EVENTS AND PROGNOSIS DURING PREGNANCY AND PERIPARTUM |
235 | COMPARISON THE PULMONARY CAPACITY IN LUNG TRANSPLANTATION PATIENTS WITH AND WITHOUT PRE-TRANSPLANTATION PULMONARY REHABILITATION |
235 | LATE-PRESENTING CONGENITAL DIAPHRAGMATIC HERNIA IN A 4-YEAR-OLD MALE: AN INCIDENTAL FINDING |
236 | EVALUATION OF INHALED DRUG PROCEDURE AMONG PATIENTS WITH ASTHMA OR COPD |
236 | THE CAUSE OF DYSPNEA WAS DIAGNOSED DURING EMERGENT ENDOTRACHEAL INTUBATION: A CASE REPORT OF TRACHEA, STENOSIS |
236 | SOCIAL MEDIA IN ACADEMIC PULMONOLOGY : #PCCP2018 EXPERIENCE |
237 | INHALER TECHNIQUE TRAINING FOR PATIENTS WITH RESPIRATORY DISEASES, SUPPORTED BY REHABILITATION THERAPISTS |
237 | QUALITY ASSESSMENT OF CLINICAL PRACTICE GUIDELINES FOR RESPIRATORY DISEASES IN CHINA IN 2017 |
238 | CATAMENIAL PNEUMOTHORAX IN THREE FILIPINO FEMALES: A CASE SERIES |
238 | FEATURES OF RADIOLOGIC DIAGNOSTICS OF RESPIRATORY CYSTIC FIBROSIS FIRST DIAGNOSED IN ADOLESCENCE |
238 | CORRELATION OF FORCED EXPIRATORY FLOW (FEF) 25–75% AND THE NUMBER OF PACK-YEARS AMONG SMOKERS |
239 | CHANGES IN CD4+CD25+FOXP3+ TREG CELLS AND INF-γ BETWEEN SUBLINGUAL AND SUBCUTANEOUS IMMUNOTHERAPY WITH HOUSE DUST MITE IN CHINESE PATIENTS WITH ALLERGIC RHINITIS |
COPD 2 |
239 | CONSUMER-LED BETTER BREATHING SUPPORT GROUPS - A HEALTH AND SOCIAL ENTERPRISE |
240 | AN ACTION PLAN FOR SELF-MANAGEMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN Republic of Korea |
240 | PREDICTIVE VALUE OF COMBINING RAPID DECLINE OF FEV1 AND INFLAMMATORY BIOMARKERS FOR DEVELOPING COPD-A PROSPECTIVE COHORT STUDY IN BEIJING |
240 | CLINICAL CHARACTERISTICS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS DETECTED WITH COPD SCREENING IN THREE DIFFERENT RURAL AREAS IN JAPAN |
241 | IMPAIRED SKELETAL MUSCLE OXYGENATION IN PEOPLE WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
241 | LOWER SERUM IMMUNOGLOBULIN FREE LIGHT CHAIN PREDICTS EXACERBATION RISK IN PATIENTS WITH COPD |
241 | INHALED STEROIDS AND RISK OF PNEUMONIA IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
242 | PATTERN OF PATIENTS DIAGNOSED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN A MEDICAL CENTER, TAIWAN, FROM 2006 TO 2017 |
242 | CLINICAL USEFULNESS OF ONCE-DAILY TRIPLE THERAPY, CICLESONIDE AND TIOTROPIUM BROMIDE / OLODATEROL COMBINATION INHALER FOR COPD PATIENTS (2ND REPORT) |
242 | THE IMPACT OF ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE DURING HOSPITALIZATION |
243 | THE LONG-TERM EFFICACY OF DOMICILIARY NON-INVASIVE POSITIVE PRESSURE VENTILATION IN COPD: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS |
243 | THE INTERPRETATION OF RESPIRATORY SYSTEM IMPEDANCE IN THE EARLY EXPIRATORY PHASE MEASURED BY FORCED OSCILLATION TECHNIQUE |
243 | COULD PROBIOTICS USEFUL FOR COPD PATIENTS? AN EBM VIEW |
244 | THE PREVALENCE OF VOIDING DYSFUNCTION AND THE EFFECT OF BRONCHODILATOR IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
244 | LONG-TERM COURSE OF EMPHYSEMA WITHOUT AIRFLOW LIMITATION |
244 | PEDOMETER AS A TOOL FOR QUALITY OF LIFE IMPROVEMENT IN COPD PATIENTS |
245 | COMPARISON OF CLINICAL CHARACTERISTICS AND INCIDENCE OF ACUTE EXACERBATION IN PATIENTS WITH ASTHMA-COPD OVERLAP AND COPD |
245 | WHOLE GENOME DNA METHYLATION ANALYSIS OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP IDENTIFIES NOVEL EPIGENETIC SIGNATURES |
246 | COPD ASSESSMENT TEST (CAT) SCORE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE BASED ON CLINICAL PHENOTYPES |
246 | WHICH IS THE ADEQUATE TIMING? BLOOD EOSINOPHIL COUNT IN PATIENTS WITH COPD EXACERBATION |
246 | ACCURACY OF PEAK EXPIRATORY FLOW RATE: HEIGHT RATIO (PEFR/HT2) MEASURED BY PORTABLE DEVICE IN PREDICTING LOW FEV1/FVC IN PATIENTS UNDERGOING SPIROMETRY AT SANTO TOMAS HOSPITAL |
247 | R-VALUE COMPREHENSIVE EVALUATION METHOD FOR THE EFFECT AND LONG-TERM INFLUENCE OF TIAOBU FEI-SHEN THERAPIES ON CHRONIC OBSTRUCTIVE PULMONARY DISEASE RATS |
247 | COMPARISON OF THREE COMBINATIONS OF INHALED LONG-ACTING MUSCARINIC ANTAGONISTS WITH LONG-ACTING BETA AGONISTS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
248 | COMPARING THE DIFFERENT DIAGNOSTIC CRITERIA OF ASTHMA-COPD OVERLAP |
248 | DIFFUSING CAPACITY OF THE LUNGS FOR CARBON MONOXIDE IS A PREDICTOR FOR EXERTIONAL DESATURATION IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
249 | THIS ABSTRACT HAS BEEN WITHDRAWN |
249 | THE PROPORTION AND CLINICAL CHARACTERISTICS OF ASTHMA-COPD OVERLAP (ACO) IN TAIWAN: A CROSS-SECTIONAL STUDY |
249 | THIS ABSTRACT HAS BEEN WITHDRAWN |
249 | STUDY REGARDING THE CLINICAL EFFICACY OF AG NPP709 (SYNATURA®) IN PATIENTS WITH CHRONIC BRONCHITIS TYPE COPD |
249 | EFFECTS OF PEDOMETER INTERVENTION ON DAILY PHYSICAL ACTIVITY AND QOL IN PATIENTS WITH COPD, INCLUDING ADDITIONAL ANALYSIS ON ACO |
250 | PREVALENCE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ASSOCIATED RISK FACTORS IN NORTH INDIA |
250 | THIS ABSTRACT HAS BEEN WITHDRAWN |
250 | SURVEY OF THE HEALTH-RELATED QUALITY-OF-LIFE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS AND DISEASE-RELATED INDIRECT BURDENS |
250 | THE VALUE OF ALLERGY SCREENING IN CHINESE ADULT PATIENTS WITH CHRONIC RESPIRATORY DISEASES |
251 | LIFE EXPECTANCY AND EXPECTED YEARS OF LIFE LOST IN PATIENTS WITH SEVERE CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
251 | THE CORRELATION OF ABSOLUTE EOSINOPHIL COUNT IN STABLE CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN FILIPINO PATIENTS |
252 | ENHANCING THE COMPETENCE OF NURSES IN COPD CARE |
252 | STUDY ON CHARACTERISTICS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH DIFFERENT PHENOTYPES |
253 | THIS ABSTRACT HAS BEEN WITHDRAWN |
253 | CARDIOPULMONARY EXERCISE TEST IN EVALUATION OF FUNCTIONAL CAPACITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
253 | EOSINOPHILIC AIRWAY INFLAMMATION AND AIRWAY HYPERRESPONSIVENESS IN COPD |
253 | THE APPLICATION OF INTELLIGENT WRISTBANDS IN THE ACUTE EXACERBATION OF COPD PATIENTS |
254 | IMPACT OF SMOKING ON COPD DEATH IN TAIWAN AND FORECASTING MORTALITY TO 2025 |
254 | DIRECT AND INDIRECT COSTS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN KOREA |
254 | QT INTERVAL AS A PREDICTOR FOR THE SEVERITY AND PROGRESSION AMONG COPD PATIENTS |
255 | FENO CONCENTRATION DISTRIBUTION IN COPD PATIENTS |
255 | PREVALENCE AND PREDICTOR FACTORS INFLUENCE OVERLAP SYNDROME AMONG COPD PATIENTS IN DR CIPTO MANGUNKUSUMO HOSPITAL JAKARTA: A CROSS SECTIONAL STUDY |
CRITICAL CARE MEDICINE 2 |
255 | MAJOR ADVERSE CARDIOVASCULAR EVENTS AND GASTROINTESTINAL BLEEDING DURING SEPSIS AND THEIR IMPACTS ON HOSPITALIZATION OUTCOMES |
256 | ELECTRICAL IMPEDANCE TOMOGRAPHY AND RESPIRATORY MECHANICS CHANGE IN TWEEN LAVAGE INDUCED ACUTE LUNG INJURY PORCINE MODEL |
256 | PROPORTIONAL ASSIST VENTILATION AS A MODE OF WEANING IN ADULT PATIENTS REQUIRING MECHANICAL VENTILATION: A META-ANALYSIS |
257 | COMPARING INDIRECT CALORIMETRY AND ESTIMATING ENERGY EQUATIONS TO EXPLORE THE ENERGY EXPENDITURE IN BILATERAL LUNG TRANSPLANT PATIENTS |
257 | THE COMPARISON OF SURGICAL AND MEDICAL PATIENTS EXPERIENCED UNPLANNED EXTUBATION |
257 | USEFULNESS OF NON-INVASIVE POSITIVE-PRESSURE VENTILATION DELIVERED BY HELMET VS FACIAL MASK IN PATIENTS WITH POST-EXTUBATIONAL RESPIRATORY DISTRESS |
258 | DIFFERENT CHARACTERISTIC PATTERN IN ICU SEPTIC PATIENTS DUE TO PNEUMONIA OR NON-PNEUMONIA |
258 | BODY MASS INDEX (BMI) CAN HELP PREDICT IMMUNE STATUS AND SHORT-TERM SURVIVAL IN PATIENTS WITH SEPSIS ADMITTED TO ICU |
258 | GENOTYPIC CHARACTERISTICS OF CARBAPENEM-RESISTANT ENTEROBACTERIACEAE IN PATIENTS WITH SEPSIS |
259 | CROSS-CULTURAL ADAPTATION AND PSYCHOMETRIC TESTING OF A CHINESE VERSION OF RESPIRATORY DISTRESS OBSERVATION SCALE |
259 | HYPERNATREMIA IN CRITICALLY ILL SEPSIS PATIENTS: A PROPENSITY SCORE ANALYSIS |
259 | TIME TO LUNG VOLUME RECOVERY AFTER SUCTIONING PREDICTS LUNG COLLAPSE AFTER PEEP DECREMENT IN RECOVERING ARDS PATIENTS |
260 | REVERSE TRIGGERING IN A PATIENT WITH CRYPTOCOCCAL MENINGITIS COMPLICATED WITH CEREBELLAR TONSILLAR HERNIATION |
260 | PROTECTIVE EFFECTS OF RAMELTEON ON ACUTE LUNG INJURY -INDUCED BY VENTILATOR IN A RAT MODEL |
261 | FLUID BALANCE IS ASSOCIATED WITH MULTI-ORGAN DYSFUNCTION SYNDROME IN PATIENTS WITH SEPTIC SHOCK IN THE ICU |
261 | BALANCED CRYSTALLOIDS VS NORMAL SALINE SOLUTION AS INTRAVENOUS FLUID THERAPY AMONG CRITICALLY ILL PATIENTS: A META-ANALYSIS |
261 | RELATIONSHIP OF RETINOPATHY OF PREMATURITY WITH AEROSOL THERAPY IN MECHANICALLY VENTILATED PRETERM INFANTS |
262 | DM SEPTIC PATIENTS ARE ASSOCIATED WITH IMPAIRED IMMUNE RESPONSE BUT NOT POOR SURVIVAL IN ICU |
262 | CASE REPORT: BILATERAL PNEUMOTORAKS OF CATAMENIAL PNEUMOTHORAX WITH MULTIPLE BULLAE |
262 | CLINICAL OUTCOMES IN PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) IN VIETNAM ACCORDING TO SEVERITY OF THE BERLIN DEFINITION |
262 | A STUDY ON THE PREDICTION OF DEATH IN ICU PATIENTS USING CRRT |
263 | ACUTE HYPERGLYCEMIA AGGRAVATES ACUTE LUNG INJURY VIA ACTIVATION OF SODIUM–POTASSIUM–CHLORIDE COTRANSPORTER 1 |
263 | FACTORS AFFECTING FAMILIES' PERCEPTION ABOUT THE PROCESS OF DECISION TO FORGO LIFE-SUSTAINING TREATMENTS |
263 | HIGH PEAKED AIRWAY PRESSURES FROM A KINKED ENDOTRACHEAL TUBE |
264 | THE MORTALITY RATE OF PRONE POSITION COMPARED WITH SUPINE POSITION FOR TREATING ARDS PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS |
264 | THE MORTALITY RATE OF LUNG RECRUITMENT MANEUVERS IN ARDS PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS |
264 | DOES MECHANICAL VENTILATION HAVE ANY ROLE IN AFFECTING SLEEP ARCHITECTURE IN CRITICALLY ILL PATIENTS? |
265 | EFFECTS OF DRIVING PRESSURE TO MORTALITY IN PATIENTS WITH SEVERE ARDS WHO RECEIVING PRONE POSITION |
ENVIRONMENTAL & OCCUPATIONAL HEALTH AND EPIDEMIOLOGY 2 |
265 | THE CIR-008885/MIR-30C/LRRC8D AXIS ENHANCES THE MACROPHAGEACTIVATION INDUCED BY SILICA |
266 | ASSESSMENT OF THE PATHOPHYSIOLOGICAL SIZE RANGES OF AIR MICROSUSPENSIONS CAUSING DEVELOPMENT AND PROGRESSION OF RESPIRATORY DISEASES |
266 | PULMONARY TOXICITY OF CROSS-LINKED SOLUBLE POLYACRYLATE FOLLOWING INTRATRACHEAL INSTILLATION |
266 | EFFICACY AND SAFETY OF VERNONIA CINEREA PASTILLES FOR SMOKING CESSATION |
267 | SURVEY ON RESPIRATORY DISORDERS IN PRESCHOOL CHILDREN PRE AND POST ADMISSION TO PRESCHOOLS IN KANDY, CENTRAL SRI LANKA |
267 | SURVEY OF RESPIRATORY SYMPTOMS AMONG PRESCHOOL CHILDREN IN RESPONSE TO DOMESTIC TRIGGERS IN KANDY, CENTRAL SRI LANKA |
267 | OCCUPATIONAL LUNG CANCER: EXPERIENCE IN A MEDICAL CENTER IN SOUTHERN TAIWAN |
268 | EFFECTS OF TUNGSTEN OXIDE ON LUNGS FOLLOWING INHALATION |
268 | ANALYSIS OF CLINICAL FEATURES IN PATIENTS WITH PNEUMOCONIOSIS COMPLICATED WITH PULMONARY EMPHYSEMA |
268 | THE LEVEL AND DYNAMICS OF RESPIRATORY DISEASES MORBIDITY IN RUSSIA |
269 | COMPARISON OF OCCUPATIONAL EXPOSURE LIMITS OF CHEMICAL SUBSTANCES IN WORKPLACE BETWEEN CHINA GBZ 2.1 AND GERMAN MAK |
269 | SURVEY ON RESPIRATORY SYMPTOMS OF URBAN VS RURAL PRESCHOOL CHILDREN IN KANDY, CENTRAL SRI LANKA |
269 | A THERAPEUTIC METHOD FOR PM2.5-INDUCED LUNG INJURY BASED ON EXOSOME IN RATS |
270 | OBSTRUCTIVE AIRWAY DISEASE IN TRIBAL AND NON-TRIBAL POPULATIONS IN RURAL BENGAL, INDIA |
INTERSTITIAL LUNG DISEASE 2 |
270 | THE USE OF KETOCONAZOLE FOR THE TREATMENT OF REFRACTORY HYPERCALCAEMIA IN SARCOIDOSIS |
271 | SYMPTOMS OF INTERSTITIAL LUNG DISEASE THAT AFFECT QUALITY OF LIFE |
271 | CLINICAL CHARACTERISTICS AND OUTCOME OF PATIENTS WITH INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES COMPARED TO CONNECTIVE TISSUE DISEASE RELATED-INTERSTITIAL LUNG DISEASE AND IDIOPATHIC PULMONARY FIBROSIS |
272 | CLINICAL ANALYSIS OF THE CASES OF INTERSTITIAL PNEUMONIA COMBINED WITH MALIGNANT TUMOR ASSOCIATED WITH POLYMYOSITIS AND DERMATOMYOSITIS IN OUR HOSPITAL |
272 | PREVALENCE OF ANXIETY AND DEPRESSION AS WELL AS ITS IMPACT ON QUALITY OF LIFE IN PATIENTS WITH INTERSTITIAL LUNG DISEASE |
272 | CLINICAL PROGNOSIS OF ACUTE EXACERBATION OF COMBINED PULMONARY FIBROSIS AND EMPHYSEMA |
272 | PATTERN OF INTERSTITIAL LUNG DISEASES IN A SINGLE CENTER OF SRI LANKA |
273 | THE SERUM KL-6 LEVELS IN UNTREATED IDIOPATHIC PULMONARY FIBROSIS CAN NATURALLY DECLINE IN ASSOCIATION WITH DISEASE PROGRESSION |
273 | EFFICACY AND SAFETY ANALYSIS OF THE WHOLE LUNG LAVAGE IN TREATMENT OF PULMONARY ALVEOLAR PROTEINOSIS |
274 | B CELL ACTIVATING FACTORS IN PATIENTS WITH AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS |
274 | THE CHRONOLOGY OF PULMONARY AND CUTANEOUS MANIFESTATIONS IN SYSTEMIC SCLEROSIS RELATED INTERSTITIAL LUNG DISEASE PATIENTS: A CASE SERIES |
274 | MULTIPLE CYSTS FORMATION IN PULMONARY LUNG CHAIN DEPOSITION DISEASE (LCDD). A CASE REPORT |
274 | PULMONARY ALVEOLAR PROTEINOSIS WITH UPPER-LOBE PREDOMINANCE IN A NON-SMOKING YOUNG FEMALE |
275 | IMPACT OF PHYSICAL ACTIVITY PRIOR TO AND AFTER ANTIFIBROSIS THERAPY IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS |
275 | HISTONE DEACETYLASE 3 INDUCES ALVEOLAR EPITHELIAL-MESENCHYMAL TRANSITION UNDER HYPOXIC CONDITION |
276 | CLINICAL SIGNIFICANCE OF FERRITIN LEVELS IN BRONCHOALVEOLAR LAVAGE FLUID FROM PATIENTS WITH ANTI-AMINOACYL-TRNA SYNTHETASE ANTIBODY-POSITIVE INTERSTITIAL LUNG DISEASE |
276 | AN EXPERT QUESTIONNAIRE ANALYSIS FOR DEVELOPING IDIOPATHIC PULMONARY FIBROSIS PATIENT-REPORTED OUTCOME SCALE |
276 | IDIOPATHIC PULMONARY FIBROSIS IS A POSSIBLE RISK FACTOR FOR OSTEOPOROSIS |
277 | AN EXPERIENCE OF PULMONARY REHABILITATION IN A PATIENT WITH COMBINED PULMONARY FIBROSIS AND EMPHYSEMA: A CASE REPORT |
277 | ANALYSIS OF CLINICAL FEATURES AND COUGH CHARACTERISTICS OF PATIENTS WITH INTERSTITIAL LUNG DISEASE |
277 | ACUTE EXACERBATION OF PLEUROPARENCHYMAL FIBROELASTOSIS IN PATIENT STATUS POST HEMATOPOIETIC STEM CELL TRANSPLANTATION: A CASE REPORT |
278 | CLINICAL ANALYSIS OF 45 DIABETIC PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS |
278 | INTERVAL OF PREVIOUS X-RAY EXAMINATION IN ADVANCED LUNG CANCER WITH INTERSTITIAL PNEUMONIA |
278 | THE EXPRESSION AND SIGNIFICANCE OF P-ERK1/2, FGF2, FGFR2 IN IDIOPATHIC PULMONARY FIBROSIS AND NON-SMALL CELL LUNG CANCER |
279 | HUMIDIFIER LUNG: CHARACTERIZATION OF FEATURES AND COMPARISON TO OTHER HYPERSENSITIVITY PNEUMONITIS PHENOTYPES |
279 | A RARE CASE OF SARCOIDOSIS-TUBERCULOSIS MASQUERADING AS MALIGNANCY WITH GALAXY SIGN AND HYPERCALCAEMIA |
279 | COMBINED MARKER ASSAY, NOT THE VALUE OF A SINGLE KL-6 IN EARLY DIAGNOSIS OF IPF |
280 | DRUG-INDUCED LUNG INJURY DUE TO BEPRIDIL WITH POSITIVE DLST AFTER SPONTANEOUS IMPROVEMENT IN CLINICAL FEATURES |
LUNG CANCER 2 |
280 | THERAPEUTIC OUTCOMES IN PATIENTS WITH CT1MI-CN0M0 LUNG CANCER DOMINANT WITH GROUND GLASS OPACITY TREATED BY CARBON ION RADIOTHERAPY |
281 | THE ROLE OF PATIENT'S SELF-REPORTED HEALTH-RELATED QUALITY OF LIFE AS A PREDICTOR OF OVERALL SURVIVAL IN ADVANCED NON-SMALL CELL LUNG CANCER WITH AGE OVER 75 |
281 | CLINICAL CORRELATION BETWEEN PREOPERATIVE SERUM OXIDATIVE STRESS LEVEL AND ABERRANT DNA METHYLATION IN PERIPHERAL BLOOD OF PATIENTS WITH STAGE I LUNG ADENOCARCINOMA; A PILOT ANALYSIS |
282 | A STUDY OF CASES WITH POSTOPERATIVE RECURRENT LUNG CANCER TREATED WITH IMMUNE CHECKPOINT INHIBITORS |
282 | GENETIC VARIANTS IN THE TNF/TNFR SIGNALING PATHWAY GENES ARE ASSOCIATED WITH SURVIVAL OF NONSMALL-CELL LUNG CANCER PATIENTS |
282 | IMPROVED TREATMENT OUTCOME OF PEMBROLIZUMAB IN NSCLC PATIENTS WITH COPD |
283 | ONCOGENIC AND IMMUNE PATHWAYS CORRELATED WITH MOLECULAR PROGNOSTIC MARKER SIALYLTRANSFERASE ST3GAL3 IN NON-SMALL CELL LUNG CANCER |
283 | THE EFFECT OF EGFR MUTATION TO METASTASIS IN STAGE III-IVB LUNG ADENOCARCINOMA |
284 | FIRST GENERATION EGFR-TKIS COMPARISON IN NON-SMALL CELL LUNG CANCER PATIENTS HARBOURING SENSITIVE EGFR MUTATIONS |
284 | PEMBROLIZUMAB AS THE FIRST THERAPY FOR SYNCHRONOUS DOUBLE CANCER OF LUNG CANCER AND GASTRIC CANCER. A CASE REPORT |
285 | PREVENTING AND TREATING BRAIN METASTASES WITH THREE FIRST-LINE EGFR-TYROSINE KINASE INHIBITORS IN PATIENTS WITH EGFR MUTATION-POSITIVE ADVANCED NON-SMALL CELL LUNG CANCER |
285 | A CASE OF PRIMARY PULMONARY MONOPHASIC SYNOVIAL SARCOMA |
286 | EFFICACY OF SALVAGE CHEMOTHERAPY AFTER IMMUNE CHECKPOINT INHIBITOR IN NON-SMALL CELL LUNG CANCER PATIENTS |
286 | THE EGFR MUTATION PATTERN AFTER EPIDERMAL GROWTH FACTOR RECEPTOR-TYROSINE KINASE INHIBITORS THERAPY IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER HARBOURING ACTIVATING UNCOMMON EGFR MUTATIONS |
286 | DIABETES IS ASSOCIATED WITH THE RISK OF PROGRESSION AND PROGNOSIS IN LUNG CANCER |
287 | PRIMARY THYMIC MALIGNANT LYMPHOMA SUSPECTED OF THYMOMA: A REPORT OF TWO CASES |
287 | ESTABLISHMENT OF PRIMARY PATIENT-DERIVED CANCER CELLS OF LUNG CANCER |
287 | AN AUTOPSY CASE OF RUPTURED LIVER METASTASES FROM SMALL CELL LUNG CANCER: CASE REPORT AND LITERATURE REVIEW |
288 | DIFFERENCES IN SMALL CELL LUNG CANCER GENETIC PROFILE BETWEEN DISEASE PROGRESSION (PD) AND PARTIAL REMISSION (PR) PATIENTS AFTER THE STANDARD FIRST-LINE CHEMOTHERAPY |
288 | ANALYSIS OF ADVANCED OR POSTOPERATIVE RECURRENT NON-SMALL CELL LUNG CANCER CASES TREATED WITH NIVOLUMAB AT HOSPITALS IN NAGASAKI, JAPAN |
288 | FACTORS ASSOCIATED WITH CRIZOTINIB EFFICACY IN PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER HARBORING DIFFERENT ALK FUSION VARIANTS |
289 | A CASE OF THYMIC CARCINOMA FOUND IN MARIE-BAMBERGER SYNDROME |
289 | LIPID DROPLETS SUPPORT THE CELL GROWTH AND PROLIFERATION AND ALLEVIATE THE STARVATION INDUCED CELL DEATH IN THE LUNG CANCER CELLS |
289 | THE SUM OF TUMOR SIZE PREDICTS THE EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN NON-SMALL CELL LUNG CANCER |
290 | PRIMING OF ANTI-PD-1/ PD-L1 THERAPY BY ANTI-METABOLITE CHEMOTHERAPEUTIC AGENTS IN NSCLC |
290 | THE RELATIONSHIP OF MELANO–ASSOCIATED ANTIGEN (MAGE) A3 EXPRESSION AND BRONCHOALVEOLAR LAVAGE (BAL) CYTOLOGICAL RESULTS NSCLS AT DR SOETOMO REGIONAL HOSPITAL OF SURABAYA |
290 | APSR MEMBERSHIP SURVEY OF EGFR MOLECULAR TESTING OF NSCLC IN THE ASIA-PACIFIC REGION |
291 | INCIDENCE OF HEPATITIS B REACTIVATION DURING EGFR TYROSINE KINASE INHIBITORS TREATMENT IN NON-SMALL-CELL LUNG CANCER PATIENTS |
291 | SOMATIC GENE MUTATIONS IN PATIENTS WITH ADENOSQUAMOUS CELL CARCINOMA OF THE LUNG |
291 | CLINICAL PERSPECTIVES ON THE UNCOMMON EGFR P.L747P AND P.L747S MUTATIONS IN LUNG ADENOCARCINOMA: A CASE SERIES STUDY |
292 | RISK FACTORS FOR DISSEMINATED INTRAVASCULAR COAGULATION (DIC) IN PATIENTS WITH LUNG CANCER |
292 | THE SURVIVAL ANALYSIS OF INOPERABLE STAGE III NON-SMALL CELL LUNG CANCER WITH THE FIRST-LINE THERAPY IN SOUTHERN OF TAIWAN |
293 | RBM10 INHIBITS PROLIFERATION OF LUNG ADENOCARCINOMA VIA RAP1A-AKT-CREB SIGNALING PATHWAY |
293 | FIRST-LINE GEFITINIB, ERLOTINIB, AND AFATINIB PROVIDED SIMILAR CLINICAL EFFICACY IN PATIENTS WHO HAD STAGE IV LUNG ADENOCARCINOMA HARBORING RARE EGFR MUTATION IN TAIWAN |
293 | A CASE REPORT ON LUNG ADENOCARCINOMA IN A PREGNANT PATIENT |
293 | 1-YEAR SURVIVAL OF NON-SMALL CELLS LUNG CARCINOMA (NSCLC) PATIENTS AND INFLUENCING FACTORS |
294 | PATIENTS WHO DEVELOP FEBRILE NEUTROPENIA (FN) IN THE INITIAL REGIMEN IN PATIENTS WITH SMALL CELL LUNG CANCER(SCLC) HAVE A POOR PROGNOSIS |
294 | PINK1 REGULATES PD-L1 AND MHC-I EXPRESSION IN LUNG CANCER WITH GLYCOLYTIC PHENOTYPE |
294 | RISK FACTORS ASSOCIATED WITH THE OCCURRENCE OF LUNG CANCER IN WOMEN IN PERSAHABATAN HOSPITAL, JAKARTA |
295 | REAL-WORLD CLINICAL OUTCOMES AND PATHOLOGIC FEATURES OF BRAF V600E-MUTATED LUNG ADENOCARCINOMA PATIENTS IN TAIWAN |
295 | PRIMARY ATYPICAL NEUROENDOCRINE TUMOR OF THE THYMUS: A CASE REPORT |
296 | ANALYSIS OF INVASIVE RISK FACTORS FOR PURE SUB-CENTIMETER GROUND-GLASS NODULES |
296 | EFFECTS OF RODENT TUBER EXTRACT CAPSULES (TYPHONIUM FLAGELLIFORME) INPATIENTS WITH LUNG CANCER WHO REFUSED CHEMOTHERAPY |
296 | TREATMENT OF NON-SMALL CELL LUNG CANCER WITH ATEZOLIZUMAB: A CASE SERIES STUDY |
297 | ORAL VINORELBINE AND CISPLATIN PLUS CONCOMITANT CHEMO-RADIOTHERAPY AS INDUCTION THERAPY IN STAGE III NON-SMALL CELL LUNG CARCINOMA: RESULTS OF A MULTI-CENTER PHASE II TIAL |
297 | STUDY OF COMPARISON AMONG DIAGNOSTIC MODALITIES TO ESTABLISH THE DIAGNOSIS OF LUNG CANCER : CEA MARKER, CT-SCAN IMAGING, AND BRONCHOSCOPIC METHOD |
297 | REAL-WORLD FIRST-LINE TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN TAIWAN: A POPULATION-BASED RETROSPECTIVE STUDY |
PAEDIATRIC LUNG DISEASE 2 |
298 | ASSOCIATION BETWEEN PNEUMONIA IN PRETERM INFANTS AND GENITAL MYCOPLASMAS IN PLACENTAS |
298 | THE AVAILABILITY OF VITAMIN D TO THE AMUR REGION CHILDREN AND ADOLESCENTS WITH PATHOLOGY OF THE LUNGS |
299 | INVESTIGATION ON THE RELATION BETWEEN CHRONIC COUGH AND MYCOPLASMA PNEUMONIA CHLAMYDIA PNEUMONIA INFECTION IN CHILDREN |
299 | CURATIVE OBSERVATION ON CHILDREN WITH MYCOPLASMA PNEUMONIA TREATED BY AZITHROMYCIN AND HUMAN- R- GLOBULIN |
299 | PULMONARY SEQUESTRATION: AN UNUSUAL CAUSE OF RESPIRATORY DISTRESS IN A NEWBORN |
299 | OUTBREAK OF HUMAN METAPNEUMOVIRUS INFECTION OF CHILDREN IN BUSAN, Republic of Korea |
300 | A TEN YEARS OLD GIRL PRESENTED WITH JIA INDUCED ILD |
PULMONARY CIRCULATION 2 |
300 | RATIONAL AND DESIGN OF THE LARGEST PROSPECTIVE MULTICENTER REGISTRY STUDY ON PULMONARY EMBOLISM IN CHINA: THE CURES STUDY |
300 | HYDROGEN GAS INHALATION IS A NOVEL TREATMENT FOR PULMONARY HYPERTENSION |
301 | A CASE OF PULMONARY EMBOLISM FROM SUPERFICIAL VENOUS THROMBOSIS WITH AN UPPER EXTREMITY SOURCE IN A 35-YEAR-OLD FEMALE ON ORAL CONTRACEPTIVE PILLS |
301 | GENETIC VARIANT OF CYP4V2 ASSOCIATED WITH VENOUS THROMBOEMBOLISM: A CASE-CONTROL STUDY |
301 | ACUPUNCTURE INDUCED PULMONARY THROMBOEMBOLISM AND DEEP VEIN THROMOBOSIS: A CASE REPORT |
RESPIRATORY INFECTIONS (NON-TUBERCULOUS) 2 |
302 | THE CLINICAL FEATURES ANALYSIS OF TRACHEOBRONCHIAL FUNGAL INFECTIONS WITH TUMOR-LIKE LESION |
302 | PROSPECTIVE INVESTIGATION OF ELDERLY NON-TUBERCULOUS MYCOBACTERIA (NTM) LUNG DISEASE: THE ACTUAL TREATMENT AND THE PROGNOSIS IN CLINICAL SETTING |
302 | JOB'S SYNDROME: RECURRENT PULMONARY INFECTIONS IN PRIMARY IMMUNODEFICIENCY, A CASE REPORT |
303 | PROGNOSIS OF PATIENT WITH BRONCHIECTASIS AFTER HOSPITALIZED EXACERBATION |
303 | GENOTYPIC CHARACTERISTICS OF CARBAPENEM-RESISTANT ENTEROBACTERIACEAEIN ONE OF SECONDARY REFERRAL HOSPITAL IN Republic of Korea |
304 | THE LIMITED IMPACT OF PSYCHIATRIC DISEASE AND PSYCHOTROPHIC MEDICATION ON THE OUTCOME OF HOSPITALIZATION FOR PNEUMONIA |
304 | PREDICTORS OF 30 DAYS MORTALITY AMONG COMMUNITY-ACQUIRED PNEUMONIA PATIENTS WITH COMORBIDITY IN TERTIARY CARE HOSPITAL |
304 | MALNUTRITION ALTERS PERFORMANCE STATUS OF ELDERLY PATIENTS WITH PARAPNEUMONIC EFFUSION |
305 | A CASE REPORT: THE COEXISTENCE OF PULMONARY CRYPTOCOCCOSIS AND GRANULOMATOSIS WITH POLYANGIITIS |
305 | QUICK SOFA AND PERFORMANCE STATUS SCORING SYSTEMS PREDICT THE PROGNOSIS OF PNEUMOCOCCAL COMMUNITY-ACQUIRED PNEUMONIA |
305 | IMPLEMENTING A CARE BUNDLE APPROACH REDUCES DURATION OF LENGTH OF STAY IN COMMUNITY-ACQUIRED PNEUMONIA |
306 | LONG-TERM OBSERVATION OF ANTI–GLYCOPEPTIDOLIPID-CORE ANTIBODY TITER IN PATIENTS WITH MYCOBACTERIUM AVIUMCOMPLEX–POSITIVE LUNG DISEASE |
306 | SMALL COHORT RETROSPECTIVE STUDY MIXED CO-INFECTION OF FUNGUS IN PNEUMINA POPULATION |
306 | CANDIDAL TRACHEOBRONCHITIS AFTER TOTAL AORTIC REPLACEMENT AND THORACIC ENDOVASCULAR AORTIC REPAIR |
307 | PNEUMOCOCCAL URINARY ANTIGEN TEST USE AS A PROGNOSTIC MARKER IN PATIENTS ADMITTED WITH COMMUNITY-ACQUIRED PNEUMONIA: A PROPENSITY SCORE MATCHING STUDY |
307 | ONE CASE OF PNEUMOCONIOSIS ASSOCIATED WITH PULMONARY NOSOCOMIAL INFECTION |
307 | THREE CASES OF POM-1 METALLO-β-LACTAMASE PRODUCING PSEUDOMONAS OTITIDIS ISOLATED FROM RESPIRATORY SPECIMENS |
308 | INCIDENCE AND CLINICAL FEATURES OF COMMUNITY-ACQUIRED PNEUMONIA CAUSED BY MACROLIDE-RESISTANT MYCOPLASMA PNEUMONIAE FROM ADULTS IN JEJU |
308 | ADVANCES IN ESTABLISHMENT OF BRONCHIECTASIS ANIMAL MODEL |
308 | IS BLOOD CULTURE USEFUL IN THE MANAGEMENT OF ASPIRATION PNEUMONIA? |
309 | ORGANIZATION AND CLINIC-EPIDEMIOLOGIC ASSESSMENT OF EFFICIENCY OF THE REGIONAL PROGRAM OF RESPIRATORY INFECTIONS PREVENTION |
309 | PULMONARY INFECTION CAUSED BY NOCARDIA FARCINICA IN AN IMMUNOCOMPETENT PATIENT: A CASE REPORT AND REVIEW OF THE LITERATURE |
309 | NATURAL HISTORY OF NON-CAVITARY NODULAR BRONCHIECTATIC MYCOBACTERIUM AVIUM COMPLEX LUNG DISEASE |
309 | MICROBIOLOGICAL PATTERN OF PULMONARY INFECTION PATIENTS IN PERSAHABATAN HOSPITAL INTESIVE CARE UNIT AND IT'S CORRELATION WITH SEVERITY OF THE DISEASE MEASURE WITH APACHE II SCORE |
310 | THIS ABSTRACT HAS BEEN WITHDRAWN |
310 | ANALYSIS FOR DISTRIBUTION RANGE AND DRUG RESISTANCE OF PATHOGENIC BACTERIA IN SPUTUM OF AECOPD INPATIENTS |
310 | DISSEMINATED MYCOBACTERIUM KANSASII DISEASE IN A PATIENT WITHOUT A DIAGNOSIS OF CLINICAL IMMUNODEFICIENCY |
310 | LEGIONELLA PNEUMONIA INDUCED ACUTE RESPIRATORY DISTRESS SYNDROME: CASE SERIES OF A TERTIARY MEDICAL CENTER IN TAIWAN |
311 | IATROGENIC PLEURAL EMPYEMA CAUSED BY PROPIONIBACTERIUM ACNES |
311 | COMPARISON OF GROCOTT-GOMORI METHENAMINE SILVER AND IMMUNOFLUORESCENCE STAINING FOR DIAGNOSING PNEUMOCYSTIS PNEUMONIA: ANALYSIS INVOLVING QUANTITATIVE PCR FOR DETECTION OF PNEUMOCYSTIS JIROVECII IN BRONCHOALVEOLAR LAVAGE FLUID |
RESPIRATORY NEUROBIOLOGY AND SLEEP 2 |
311 | DIFFERENT PROFILES OF COUGH HYPERSENSITIVITY MEDIATED BY TRPV1, TRPA1 IN PATIENTS WITH CHRONIC REFRACTORY COUGH |
312 | MOTOR UNIT RECRUITMENT IN HUMAN GENIOGLOSSUS DURING FLOW-LIMITED BREATHING IN SLEEP |
312 | THE HMGB1-RAGE/TLR-TNF-α SIGNALING PATHWAY MAY CONTRIBUTE TO KIDNEY INJURY INDUCED BY HYPOXIA |
312 | COMBINATION OF NON CPAP THERAPY IN PATIENTS WITH OSA |
313 | A RETROSPECTIVE ANALYSIS ON THE DEMOGRAPHIC CHARACTERISTICS OF PATIENTS WITH EXCESSIVE DAYTIME SLEEPINESS PRESENTING TO THE SLEEP MEDICINE CLINIC HOSPITAL TAIPING |
313 | GETTING OLDER IS ASSOCIATED WITH THE INCREASED RISK FOR OSA AND HYPOVENTILATION IN PATIENTS WITH DUCHENNE MUSCULAR DYSTROPHY |
314 | NORADRENERGIC A7 CELL GROUP MODULATES THE CENTRAL REGULATION OF GENIOGLOSSUSIN RATS |
314 | A PREDICTION EQUATION OF OPTIMAL CPAP PRESSURE FOR OBSTRUCTIVE SLEEP APNEA IN MALAYSIA |
314 | SLEEP EFFICIENCY AND NOCTURNAL DESATURATION ASSOCIATED WITH HYPERTENSION |
315 | EPIDEMIOLOGICAL CHARACTERISTIC OF ISCHEMIC STROKE IN ADULTS INDONESIAN OBSTRUCTIVE SLEEP APNEA POPULATION: A PRELIMINARY STUDY |
RESPIRATORY STRUCTURE AND FUNCTION 2 |
315 | EFFECT OF MODERATE ENDURANCE TRAINING ON EXERCISE BIOLOGICAL CALIBRATION |
316 | EFFECTS OF DIFFERENT-INTENSITY INSPIRATORY MUSCLE TRAINING ON DIAPHRAGM AND ASSISTIVE INSPIRATORY MUSCLE THICKNESS IN HEALTHY INDIVIDUALS |
316 | RIGHT UNILATERAL PULMONARY APLASIA: A CASE REPORT |
316 | THE EFFECTS OF SCAPULA AND TRUNK MUSCLE TRAINING ON MOUTH PRESSURE |
317 | SWOT ANALYSIS ON THE PROMOTION OF PULMONARY FUNCTION TEST IN PRIMARY MEDICAL AND HEALTH SERVICE INSTITUTIONS |
317 | DIFFERENCES BETWEEN THIRACIC AND ABDOMINAL RESPIRATION IN MOSTGRAPH ANALYSIS |
317 | A 6-WEEK OLD INFANT WITH FIRST EPISODE OF COUGH DIAGNOSED WITH BRONCHUS SUIS: A CASE REPORT |
318 | SHORT-TERM INSPIRATORY MUSCLE TRAINING IN HOSPITALIZED HEART FAILURE PATIENTS IS SAFE AND EFFECTIVE FOR IMPROVING INSPIRATORY MUSCLE STRENGTH AND DYSPNOEA ON EXERTION |
318 | DECREASED LUNG FUNCTION IS ASSOCIATED WITH INCREASED RISK OF DEVELOPING NON-ALCOHOLIC FATTY LIVER DISEASE: A LONGITUDINAL COHORT STUDY |
TUBERCULOSIS 2 |
318 | ANALYSIS OF AGE-SPECIFIC BACKGROUND OF ACTIVE TUBERCULOSIS IN AIZU MEDICAL CENTER, JAPAN |
319 | REDUCING TUBERCULOSIS BUT CONTRACTING SHINGLES IN PATIENTS WITH TYPE 2 DIABETES RECEIVING STATIN VS NONSTATIN LIPID LOWERING AGENTS |
319 | INCIDENCE OF ACTIVE TUBERCULOSIS WITHIN 1 YEAR AFTER TUMOR NECROSIS FACTOR INHIBITOR TREATMENT ACCORDING TO LTBI STATUS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE |
319 | DECREASED MIR-150-5P EXPRESSION IN PATIENTS WITH ACTIVE PULMONARY TUBERCULOSIS (TB) DISEASE |
320 | CORRELATION BETWEEN MATRIX METALLOPROTEINASE-9 AND THE SEVERITY DEGREE OF CHEST X-RAY IN PULMONARY TUBERCULOSIS PATIENTS |
320 | DIFFERENTIATION BETWEEN LYMPHOMA ASSOCIATED EFFUSIONS AND TUBERCULOUS PLEURAL EFFUSION |
320 | ANALYSIS OF TB SURVEILLANCE DATA ON FOREIGN-BORN PERSONS "TRANSFERRING OUT" IN JAPAN - IMPLICATIONS FOR CROSS-BORDER COLLABORATION FOR TB CARE AND PREVENTION |
321 | THE ROLE OF SURGERY FOR THE TREATMENT OF INCIDENTAL PULMONARY TUBERCULOSIS FINDING IN A TUBERCULOSIS-ENDEMIC COUNTRY |
321 | THE GREAT MIMICKER: PULMONARY TUBERCULOSIS WITH AXILLARY MASS |
322 | A RARE CASE OF ANTERIOR MEDIASTINAL MASS IN A 12 MONTH OLD: TUBERCULOSIS |
322 | VITAMIN D, SERUM IL-15 AND SERUM IP-10 ARE POTENTIAL BIOMARKERS TO DIFFERENTIATE ACTIVE TB AND LATENT TB |
323 | RISK FACTORS OF TIME ADVERSE EFFECTS OF KANAMISIN ON TUBERCULOSIS DRUG RESISTANT |
323 | THE GREAT MASQUERADER: A CASE REPORT ON PULMONARY TUBERCULOSIS AND LUNG CANCER |
323 | 'TENNIS RACKET' SIGN: AN OBLIVION PREDICTOR OF ACTIVE TUBERCULOSIS |
323 | ANALYSIS OF AGE-SPECIFIC CT FINDINGS OF ACTIVE TUBERCULOSIS IN AIZU MEDICAL CENTER, JAPAN |
324 | KNOWLEDGE, ATTITUDES AND BEHAVIOUR PATIENT SUSPECT MDR-TB AT PULMONARY HEALTH CENTER (BKPM) IN MALUKU-INDONESIA |
324 | CLINICAL FACTORS ASSOCIATED WITH INITIATION OF LTBI TREATMENT AMONG HEALTH CARE WORKERS IN A REFERRAL HOSPITAL IN KOREA |
324 | SPECTRUM OF TUBERCULOSIS IN ADVANCED CHRONIC KIDNEY DISEASE (ACKD) |
325 | PULMONARY TUBERCULOSIS IN ADVANCED CHRONIC KIDNEY DISEASE; A DESCRIPTIVE STUDY ON DISEASE PATTERN AND TREATMENT OUTCOME IN A HIGH CKD PREVALENT SETTING |
326 | THE IMPORTANT OF RAPID MOLECULAR TEST IN TB DIAGNOSIS AND PROMPT TREATMENT |
326 | THE TREND OF TUBERCULOSIS RESEARCH IN NORTH KOREA BASED ON A REVIEW OF LITERATURE |
326 | A FILIPINO WITH MULTIPLE SACCULAR ANEURYSMS CAUSED BY MYCOBACTERIUM TUBERCULOSIS |
327 | THE INFLUENCE OF COMPLICATION OF INTERSTITIAL LUNG DISEASE TO MORTALITY AND LENGTH OF STAY IN WARD FOR THE PATIENTS WITH PULMONARY TUBERCULOSIS |
327 | DIAGNOSTIC DISCREPANCY, A DRUG SENSITIVE OR MDR-TB : CASE REPORT |
327 | QUALITY OF LIFE OF PATIENTS WITH MULTI-DRUG RESISTANT TUBERCULOSIS AT PROGRAMMATIC MANAGEMENT OF DRUG-RESISTANT TUBERCULOSIS WESTERN VISAYAS MEDICAL CENTER JANUARY 2013 TO APRIL 2015 PHILIPPINES |
327 | SUCCESSFUL DESENSITIZATION FOR ANTI-TUBERCULOSIS HYPERSENSITIVITY DRUG REACTION: A CASE SERIES |
328 | ABDOMINAL TUBERCULOSIS MANAGED SURGICALLY IN THE LATE PHASE:A CASE REPORT |
328 | LATENT TUBERCULOSIS INFECTION ON HEALTHCARE WORKER IN WEST SUMATERA PULMONARY HOSPITAL |
CRITICAL CARE MEDICINE 2 |
328 | STATIN TREATMENT MAY PREVENT DEVELOPMENT OF ACTIVE TUBERCULOSIS IN DIABETIC STATE: AN ANALYSIS OF A NATIONALLY REPRESENTATIVE COHORT |
RESPIRATORY INFECTIONS (NON-TUBERCULOUS) 2 |
329 | THE DIAGNOSIS VALUE OF BRONCHOALVEOLAR LAVAGE DETECTION BY HIGH-THROUGHPUT SEQUENCING FOR PULMONARY INFECTIOUS DISEASES |
329 | HOSPITAL-ACQUIRED PNEUMONIA RATE IN A HOSPITAL AFFILIATED UNIVERSITY IN CHINA: A CROSS-SECTIONAL SURVEY INVOLVING 210417 INPATIENTS |
CRITICAL CARE MEDICINE 1 |
330 | INFLUENZA A PANDEMIC (H1N1) 2009 VIRUS INFECTION WITH DEATH LIMB EXTREMITIES INFERIOR AND ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS): A CASE REPORT |
INTERSTITIAL LUNG DISEASE 1 |
330 | CLINICAL COURSES AND TREATMENT EFFECTS IN SYSTEMIC SCLERODERMA-RELATED INTERSTITIAL LUNG DISEASE |
COPD 2 |
330 | PERCEPTION OF SYMPTOMS AND PATIENT'S VIEW IN COPD- MARKERS OF CHANGING NEEDS |
RESPIRATORY INFECTIONS (NON-TUBERCULOUS) 1 |
331 | CHARACTERISTICS OF HOSPITAL-ACQUIRED PNEUMONIA PATIENTS WITH MULTIDRUG-RESISTANT BACTERIAL INFECTION IN DR CIPTO MANGUNKUSUMO GENERAL HOSPITAL INDONESIA |
RESPIRATORY INFECTIONS (NON-TUBERCULOUS) 2 |
331 | IDENTIFYING OF RISK FACTORS OF MULTI-DRUG RESISTANT BACTERIA IN HOSPITALIZED ACQUIRED PNEUMONIA |
COPD 1 |
331 | ASSOCIATION OF SERUM URIC ACID LEVELS AND OUTCOMES OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A PROSPECTIVE COHORT STUDY |
LUNG CANCER 1 |
332 | A META-ANALYSIS ON INDWELLING PLEURAL CATHETERS VERSUS PLEURODESIS IN THE MANAGEMENT OF MALIGNANT PLEURAL EFFUSIONS: A MODERN DILEMMA |
CRITICAL CARE MEDICINE 2 |
332 | ACCURACY OF GAS EXCHANGE MEASUREMENTS AS PREDICTORS OF EARLY SUCCESSFUL WEANING AMONG ICU PATIENTS OF PHILIPPINE HEART CENTER: A PROSPECTIVE COHORT STUDY |
CRITICAL CARE MEDICINE 1 |
333 | ASSESSMENT OF QUALITY OF SLEEP IN PATIENTS RECOVERING FROM CRITICAL CARE ILLNESS AND FACTORS AFFECTING IT |
AUTHOR INDEX |
335 | AUTHOR INDEX |